Botulinum Toxin Market by Product (Toxin Type A and Toxin Type B), by Application (Therapeutic and Aesthetic), by Gender (Male and Female), by Age Group (13-19, 20-29, 30-39, 40-54, 55 and above), and by End-User (Hospitals, Dermatology Clinics, and Spas & Cosmetic Centers) - Global Opportunity Analysis and Industry Forecast 2022-2030

Botulinum Toxin Market

Industry:  Life Sciences & Healthcare | Publish Date: May 2022 | No of Pages:  428 | No. Tables:  245 | No. Figures:  212

Market Definition:

The global Botulinum Toxin Market size was valued at USD 4.06 billion in 2021 and is predicted to reach USD 8.72 billion by 2030 with a CAGR of 8.3% from 2022-2030.

Botulinum toxin (BTX) is a type of toxin produced by a bacteria called clostridium botulinum, one of the most poisonous biological substances on earth. It acts as a neurotoxin, which is destructive to nerve tissues. This toxin was initially used to treat disorders such as blepharospasm, an abnormal contraction of the eyelid muscles and strabismus, a condition in which eyes do not line up with one another. It is the first biological toxin in the world that is licensed as a drug for treating diseases such as migraines, overactive bladder, and excessive sweating disorder. In addition, the cosmetic form of botulinum toxin, popularly known as Botox is widely used by cosmetic surgeons to reduce facial wrinkles and creases.

Market Dynamics and Trends:

Increasing demand of botulinum toxins such as Dysport and Jeuveau, in the cosmetic industry is driving the growth of botulinum toxin market. Dysport and Jeuveau are extensively used for skin revitalization due to their ability to reduce wrinkles by temporarily paralyzing facial muscles. Also, increasing cases of stress-triggered migraine and chronic cluster headaches across the globe that requires botulinum toxin for cure, are further driving the growth of the market. 

Moreover, upsurge in the therapeutic applications of botulinum toxin, have encouraged key market players such as Revance Therapeutics Inc, Merz Pharma, Ipsen, and Medy tox Inc to invest heavily in research and development. For instance, in 2020, Revance Therapeutics Inc. had invested USD 125.8 million in research and development of botulinum toxin related products.

However, side effects of botulinum toxin, such as pain, swelling or bruising at the injection site, and eye dryness or excessive tearing are restraining the growth of botulinum toxin market. Also, availability of non-regulated counterfeit botulinum products that compromises quality and sterility causes severe risk of botulinum toxin overdose and further restrain the market growth. On the contrary, development of new and advanced botulinum toxin products such as Meditoxin and METOX, that can be used for the treatment of hemifacial spasm, is expected to create ample growth opportunities for the market in the upcoming years.

Market Segmentations and Scope of the Study:

The botulinum toxin market is segmented on the basis of product, application, gender, age group, end-user, and geography. On the basis of product, the market is divided into toxin type A and toxin type B. On the basis of application, the market is classified into therapeutic and aesthetic. The therapeutic market is further sub-segmented into chronic migraine, spasticity, overactive bladder, cervical dystonia, blepharospasm, axillary hyperhidrosis, and others. On the basis of gender, the market is categorized into male and female. On the basis of age group, the market is divided into 13-19, 20-29, 30-39, 40-54, 55 and above. On the basis of end-user, the market is classified into hospitals, dermatology clinics, and spas & cosmetic centers. Geographic breakdown and analysis of each of the aforesaid segments includes regions comprising of North America, Europe, Asia-Pacific, and RoW.

Geographical Analysis:

North America holds the lion share of the botulinum toxin market and is expected to dominate the market throughout the forecast period. This is attributed to factors such as high spending capacity and huge demand for aesthetic products and services among the population in this region. For instance, according to the American Society of Plastic Surgeons, nearly 15.6 million cosmetic procedures and 6.8 million reconstructive procedures has been performed in the United States in 2020 alone.

Asia-pacific is expected to show a steady rise in the botulinum toxin market due to the rapidly rising adoption of this toxin by the people in this region, along with increasing research and development initiatives by major market players such as Medy tox Inc. and Lanzhou Institute of Biological Products Co. Ltd. to expand the therapeutic applications of botulinum toxin. Also, rising concerns related to aesthetics such as lateral canthal lines and crow’s foot, are some of the major factors contributing to the growth of botulinum toxin market in the region.

Competitive Landscape:

The botulinum toxin market comprises of various market players such Abbvie Inc., Evolus Inc., Revance Therapeutics Inc., Sun Pharmaceutical Industries Ltd., Merz Pharma, Ipsen, Medy tox Inc., Galderma, , Hugel Inc., US WorldMeds LLC., and Eisai Co. Ltd. These market players are aggressively conducting R&D, developing new products, and applying for government approvals and clearances to stay competitive and maintain their market positions. 

For instance, in August 2021, Merz Therapeutics announced that it had received approval from the European authorities for the use of Xeomin, a neurotoxin for the treatment of chronic sialorrhea (drooling) due to neurodevelopmental disorders that affect the development of the nervous system in children between 2 to 17 years of age. Moreover, in January 2020, a botulinum toxin product of Ipsen pharma Dysport, received a license update from U.K.’s medicine and healthcare products regulatory agency (MHRA). Dysport is used for treating muscle stiffness of upper limbs in children with cerebral palsy, a brain neurological disorder that causes problems with normal motor function that does not allow the body to move, talk or eat.

KEY BENEFITS:

  • The botulinum toxin market report provides the quantitative analysis of the current market and estimations through 2022-2030 that assists in identifying the prevailing market opportunities to capitalize on.

  • The study comprises a deep dive analysis of the botulinum toxin market trend including the current and future trends for depicting the prevalent investment pockets in the market.

  • The information related to key drivers, restraints and opportunities and their impact on the botulinum toxin market is provided in the report.

  • The competitive analysis of the market players along with their market share in the botulinum toxin market

  • The SWOT analysis and Porters Five Forces model is elaborated in the study.

  • Value chain analysis in the market study provides a clear picture of the stakeholders’ roles.

KEY MARKET SEGMENTS:

By Product

  • Toxin Type A

  • Toxin Type B

By Application

  • Therapeutic

    • Chronic Migraine

    • Spasticity

    • Overactive Bladder

    • Cervical Dystonia

    • Blepharospasm

    • Axillary Hyperhidrosis

    • Others

  • Aesthetic

By Gender

  • Male

  • Female

By Age Group

  • 13-19

  • 20-29

  • 30-39

  • 40-54

  • 55 and above

By End-User

  • Hospitals

  • Dermatology Clinics

  • Spas & Cosmetic Centers

By Geography

  • North America

    • U.S

    • Canada

    • Mexico

  • Europe

    • UK

    • Germany

    • France

    • Spain

    • Italy

    • Netherlands

    • Rest of Europe

  • Asia-Pacific

    • China

    • Japan

    • India

    • Australia

    • South Korea

    • Taiwan

    • Vietnam

    • Rest of Asia-Pacific

  • RoW

    • Latin America

    • Middle East

    • Africa

REPORT SCOPE AND SEGMENTATION:

Parameters

Details

Analysis Period

2021–2030

Base Year Considered

2021

Forecast Period

2022–2030

Market Size Estimation

Billion (USD)

Market Segmentation

By Product (Toxin Type A and Toxin Type B), by Application (Therapeutic and Aesthetic), by Gender (Male and Female), by Age Group (13-19, 20-29, 30-39, 40-54, 55 and above), and by End-User (Hospitals, Dermatology Clinics, and Spas & Cosmetic Centers)

Geographical Segmentation

North America (U.S., Canada, Mexico) Europe (UK, Germany, France, Spain, Italy, Netherlands, Rest of Europe), Asia-Pacific (China, Japan, India, Australia, South Korea, Taiwan, Vietnam, Rest of Asia-Pacific, Vietnam), Rest of the World (Latin America, Middle East, Africa)

Companies Profiled

Abbvie Inc., Evolus Inc., Revance Therapeutics Inc., Sun Pharmaceutical Industries Ltd., Merz Pharma, Ipsen, Medy tox Inc., Galderma, Hugel Inc., US WorldMeds LLC., and Eisai Co. Ltd.

1.... INTRODUCTION

1.1.           REPORT DESCRIPTION

1.2.           Who should read this report 

1.3.           KEY MARKET SEGMENTS

1.4.           Research Methodology

1.4.1             Secondary Research

1.4.2             Data Analysis Framework

1.4.3             Market size estimation

1.4.4             Forecasting

1.4.5             Primary Research and Data Validation

2.... Botulinum Toxin Market – Executive Summary

2.1.           Market Snapshot, 2020 - 2030, Million USD

3.... MARKET OVERVIEW

3.1.           MARKET DEFINITION AND SCOPE

3.2.           MARKET DYNAMICS

3.2.1             Drivers

3.2.1.1        The surge in product development and approvals

3.2.1.2        Upsurge in Demand for Aesthetic Procedures

3.2.1.3        Expanding therapeutic use of botulinum toxin

3.2.2             Restraints

3.2.2.1        Short time results and repetitive nature of aesthetic and therapeutic procedures

3.2.2.2        Adverse effects associated with Botulinum Toxin

3.2.3             Opportunities

3.2.3.1        Large untapped population in emerging countries

4.... Covid-19 Analysis

4.1.           Impact of Covid-19 On the Market

5.... Market Share ANALYSIS

5.1.           Market share analysis of top Acne medication Providers, 2020

6.... Global Botulinum Toxin Market, By Product Type

6.1.           Overview

6.2.           Toxin Type A

6.2.1             Toxin Type A Market, By Region

6.2.1.1        North America Toxin Type A Market, By Country

6.2.1.2        Europe Toxin Type A Market, By Country

6.2.1.3        Asia-Pacific Toxin Type A Market, By Country

6.2.1.4        Rest of World Toxin Type A Market, By Country

6.3.           Toxin Type B

6.3.1             Toxin Type B Market, By Region

6.3.1.1        North America Toxin Type B Market, By Country

6.3.1.2        Europe Toxin Type B Market, By Country

6.3.1.3        Asia-Pacific Toxin Type B Market, By Country

6.3.1.4        Rest of World Toxin Type B Market, By Country

7.... Global Botulinum Toxin Market, By Application

7.1.           Overview

7.2.           Therapeutic

7.2.1             Global Therapeutic Market, By Application

7.2.1.1        Chronic Migraine Market

7.2.1.2        Chronic Migraine Market, By Region

7.2.1.2.1        North America Chronic Migraine Market, By Country

7.2.1.2.2        Europe Chronic Migraine Market, By Country

7.2.1.2.3        Asia-Pacific Chronic Migraine Market, By Country

7.2.1.2.4        Rest of World Chronic Migraine Market, By Country

7.2.1.3        Spasticity Market

7.2.1.4        Spasticity Market, By Region

7.2.1.4.1        North America Spasticity Market, By Country

7.2.1.4.2        Europe Spasticity Market, By Country

7.2.1.4.3        Asia-Pacific Spasticity Market, By Country

7.2.1.4.4        Rest of World Spasticity Market, By Country

7.2.1.5        Overactive Bladder Market

7.2.1.6        Overactive Bladder Market, By Region

7.2.1.6.1        North America Overactive Bladder Market, By Country

7.2.1.6.2        Europe Overactive Bladder Market, By Country

7.2.1.6.3        Asia-Pacific Overactive Bladder Market, By Country

7.2.1.6.4        Rest of World Overactive Bladder Market, By Country

7.2.1.7        Cervical Dystonia Market

7.2.1.8        Cervical Dystonia Market, By Region

7.2.1.8.1        North America Cervical Dystonia Market, By Country

7.2.1.8.2        Europe Cervical Dystonia Market, By Country

7.2.1.8.3        Asia-Pacific Cervical Dystonia Market, By Country

7.2.1.8.4        Rest of World Cervical Dystonia Market, By Country

7.2.1.9        Blepharospasm Market

7.2.1.10      Blepharospasm Market, By Region

7.2.1.10.1      North America Blepharospasm Market, By Country

7.2.1.10.2      Europe Blepharospasm Market, By Country

7.2.1.10.3      Asia-Pacific Blepharospasm Market, By Country

7.2.1.10.4      Rest of World Blepharospasm Market, By Country

7.2.1.11      Axillary Hyperhidrosis Market

7.2.1.12      Axillary Hyperhidrosis Market, By Region

7.2.1.12.1      North America Axillary Hyperhidrosis Market, By Country

7.2.1.12.2      Europe Axillary Hyperhidrosis Market, By Country

7.2.1.12.3      Asia-Pacific Axillary Hyperhidrosis Market, By Country

7.2.1.12.4      Rest of World Axillary Hyperhidrosis Market, By Country

7.2.1.13      Others Market

7.2.1.14      Others Market, By Region

7.2.1.14.1      North America Others Market, By Country

7.2.1.14.2      Europe Others Market, By Country

7.2.1.14.3      Asia-Pacific Others Market, By Country

7.2.1.14.4      Rest of World Others Market, By Country

7.2.2             Therapeutic Market, By Region

7.2.2.1        North America Therapeutic Market, By Country

7.2.2.2        Europe Therapeutic Market, By Country

7.2.2.3        Asia-Pacific Therapeutic Market, By Country

7.2.2.4        Rest of World Therapeutic Market, By Country

7.3.           Aesthetic

7.3.1             Aesthetic Market, By Region

7.3.1.1        North America Aesthetic Market, By Country

7.3.1.2        Europe Aesthetic Market, By Country

7.3.1.3        Asia-Pacific Aesthetic Market, By Country

7.3.1.4        Rest of World Aesthetic Market, By Country

8.... Global Botulinum Toxin Market, By Gender

8.1.           Overview

8.2.           Male

8.2.1             Male Market, By Region

8.2.1.1        North America Male Market, By Country

8.2.1.2        Europe Male Market, By Country

8.2.1.3        Asia-Pacific Male Market, By Country

8.2.1.4        Rest of World Male Market, By Country

8.3.           Female

8.3.1             Female Market, By Region

8.3.1.1        North America Female Market, By Country

8.3.1.2        Europe Female Market, By Country

8.3.1.3        Asia-Pacific Female Market, By Country

8.3.1.4        Rest of World Female Market, By Country

9.... Global Botulinum Toxin Market, By Age Group

9.1.           Overview

9.2.-19

9.2.1-19 Market, By Region

9.2.1.1        North America 13-19 Market, By Country

9.2.1.2        Europe 13-19 Market, By Country

9.2.1.3        Asia-Pacific 13-19 Market, By Country

9.2.1.4        Rest of World 13-19 Market, By Country

9.3.-29

9.3.1-29 Market, By Region

9.3.1.1        North America 20-29 Market, By Country

9.3.1.2        Europe 20-29 Market, By Country

9.3.1.3        Asia-Pacific 20-29 Market, By Country

9.3.1.4        Rest of World 20-29 Market, By Country

9.4.-39

9.4.1-39 Market, By Region

9.4.1.1        North America 30-39 Market, By Country

9.4.1.2        Europe 30-39 Market, By Country

9.4.1.3        Asia-Pacific 30-39 Market, By Country

9.4.1.4        Rest of World 30-39 Market, By Country

9.5.-54

9.5.1-54 Market, By Region

9.5.1.1        North America 40-54 Market, By Country

9.5.1.2        Europe 40-54 Market, By Country

9.5.1.3        Asia-Pacific 40-54 Market, By Country

9.5.1.4        Rest of World 40-54 Market, By Country

9.6. and above

9.6.1 and above Market, By Region

9.6.1.1        North America 55 and above Market, By Country

9.6.1.2        Europe 55 and above Market, By Country

9.6.1.3        Asia-Pacific 55 and above Market, By Country

9.6.1.4        Rest of World 55 and above Market, By Country

10.. Global Botulinum Toxin Market, By End-User

10.1.         Overview

10.2.         Hospitals

10.2.1           Hospitals Market, By Region

10.2.1.1      North America Hospitals Market, By Country

10.2.1.2      Europe Hospitals Market, By Country

10.2.1.3      Asia-Pacific Hospitals Market, By Country

10.2.1.4      Rest of World Hospitals Market, By Country

10.3.         Dermatology Clinics

10.3.1           Dermatology Clinics Market, By Region

10.3.1.1      North America Dermatology Clinics Market, By Country

10.3.1.2      Europe Dermatology Clinics Market, By Country

10.3.1.3      Asia-Pacific Dermatology Clinics Market, By Country

10.3.1.4      Rest of World Dermatology Clinics Market, By Country

10.4.         Spas & Cosmetic Centers

10.4.1           Spas & Cosmetic Centers Market, By Region

10.4.1.1      North America Spas & Cosmetic Centers Market, By Country

10.4.1.2      Europe Spas & Cosmetic Centers Market, By Country

10.4.1.3      Asia-Pacific Spas & Cosmetic Centers Market, By Country

10.4.1.4      Rest of World Spas & Cosmetic Centers Market, By Country

11.. Global Botulinum Toxin Market, By Region

11.1.         Overview

11.2.         North America

11.2.1           North America Botulinum Toxin Market, By Product Type

11.2.2           North America Botulinum Toxin Market, By Application

11.2.2.1      North America Therapeutic Market, By Application

11.2.3           North America Botulinum Toxin Market, By Gender

11.2.4           North America Botulinum Toxin Market, By Age Group

11.2.5           North America Botulinum Toxin Market, By End-User

11.2.6           North America Botulinum Toxin Market, By Country

11.2.6.1      U.S.

11.2.6.1.1      U.S. Botulinum Toxin Market, By Product Type

11.2.6.1.2      U.S. Botulinum Toxin Market, By Application

11.2.6.1.2.1. U.S. Therapeutic Market, By Application

11.2.6.1.3      U.S. Botulinum Toxin Market, By Gender

11.2.6.1.4      U.S. Botulinum Toxin Market, By Age Group

11.2.6.1.5      U.S. Botulinum Toxin Market, By End-User

11.2.6.2      Canada

11.2.6.2.1      Canada Botulinum Toxin Market, By Product Type

11.2.6.2.2      Canada Botulinum Toxin Market, By Application

11.2.6.2.2.1. Canada Therapeutic Market, By Application

11.2.6.2.3      Canada Botulinum Toxin Market, By Gender

11.2.6.2.4      Canada Botulinum Toxin Market, By Age Group

11.2.6.2.5      Canada Botulinum Toxin Market, By End-User

11.2.6.3      Mexico

11.2.6.3.1      Mexico Botulinum Toxin Market, By Product Type

11.2.6.3.2      Mexico Botulinum Toxin Market, By Application

11.2.6.3.2.1. Mexico Therapeutic Market, By Application

11.2.6.3.3      Mexico Botulinum Toxin Market, By Gender

11.2.6.3.4      Mexico Botulinum Toxin Market, By Age Group

11.2.6.3.5      Mexico Botulinum Toxin Market, By End-User

11.3.         Europe

11.3.1           Europe Botulinum Toxin Market, By Product Type

11.3.2           Europe Botulinum Toxin Market, By Application

11.3.2.1      Europe Therapeutic Market, By Application

11.3.3           Europe Botulinum Toxin Market, By Gender

11.3.4           Europe Botulinum Toxin Market, By Age Group

11.3.5           Europe Botulinum Toxin Market, By End-User

11.3.6           Europe Botulinum Toxin Market, By Country

11.3.6.1      UK

11.3.6.1.1      UK Botulinum Toxin Market, By Product Type

11.3.6.1.2      UK Botulinum Toxin Market, By Application

11.3.6.1.2.1. UK Therapeutic Market, By Application

11.3.6.1.3      UK Botulinum Toxin Market, By Gender

11.3.6.1.4      UK Botulinum Toxin Market, By Age Group

11.3.6.1.5      UK Botulinum Toxin Market, By End-User

11.3.6.2      Germany

11.3.6.2.1      Germany Botulinum Toxin Market, By Product Type

11.3.6.2.2      Germany Botulinum Toxin Market, By Application

11.3.6.2.2.1. Germany Therapeutic Market, By Application

11.3.6.2.3      Germany Botulinum Toxin Market, By Gender

11.3.6.2.4      Germany Botulinum Toxin Market, By Age Group

11.3.6.2.5      Germany Botulinum Toxin Market, By End-User

11.3.6.3      France

11.3.6.3.1      France Botulinum Toxin Market, By Product Type

11.3.6.3.2      France Botulinum Toxin Market, By Application

11.3.6.3.2.1. France Therapeutic Market, By Application

11.3.6.3.3      France Botulinum Toxin Market, By Gender

11.3.6.3.4      France Botulinum Toxin Market, By Age Group

11.3.6.3.5      France Botulinum Toxin Market, By End-User

11.3.6.4      Spain

11.3.6.4.1      Spain Botulinum Toxin Market, By Product Type

11.3.6.4.2      Spain Botulinum Toxin Market, By Application

11.3.6.4.2.1. Spain Therapeutic Market, By Application

11.3.6.4.3      Spain Botulinum Toxin Market, By Gender

11.3.6.4.4      Spain Botulinum Toxin Market, By Age Group

11.3.6.4.5      Spain Botulinum Toxin Market, By End-User

11.3.6.5      Italy

11.3.6.5.1      Italy Botulinum Toxin Market, By Product Type

11.3.6.5.2      Italy Botulinum Toxin Market, By Application

11.3.6.5.2.1. Italy Therapeutic Market, By Application

11.3.6.5.3      Italy Botulinum Toxin Market, By Gender

11.3.6.5.4      Italy Botulinum Toxin Market, By Age Group

11.3.6.5.5      Italy Botulinum Toxin Market, By End-User

11.3.6.6      Netherlands

11.3.6.6.1      Netherlands Botulinum Toxin Market, By Product Type

11.3.6.6.2      Netherlands Botulinum Toxin Market, By Application

11.3.6.6.2.1. Netherlands Therapeutic Market, By Application

11.3.6.6.3      Netherlands Botulinum Toxin Market, By Gender

11.3.6.6.4      Netherlands Botulinum Toxin Market, By Age Group

11.3.6.6.5      Netherlands Botulinum Toxin Market, By End-User

11.3.6.7      Rest of Europe

11.3.6.7.1      Rest of Europe Botulinum Toxin Market, By Product Type

11.3.6.7.2      Rest of Europe Botulinum Toxin Market, By Application

11.3.6.7.2.1. Rest of Europe Therapeutic Market, By Application

11.3.6.7.3      Rest of Europe Botulinum Toxin Market, By Gender

11.3.6.7.4      Rest of Europe Botulinum Toxin Market, By Age Group

11.3.6.7.5      Rest of Europe Botulinum Toxin Market, By End-User

11.4.         Asia-Pacific

11.4.1           Asia-Pacific Botulinum Toxin Market, By Product Type

11.4.2           Asia-Pacific Botulinum Toxin Market, By Application

11.4.2.1      Asia-Pacific Therapeutic Market, By Application

11.4.3           Asia-Pacific Botulinum Toxin Market, By Gender

11.4.4           Asia-Pacific Botulinum Toxin Market, By Age Group

11.4.5           Asia-Pacific Botulinum Toxin Market, By End-User

11.4.6           Asia-Pacific Botulinum Toxin Market, By Country

11.4.6.1      China

11.4.6.1.1      China Botulinum Toxin Market, By Product Type

11.4.6.1.2      China Botulinum Toxin Market, By Application

11.4.6.1.2.1. China Therapeutic Market, By Application

11.4.6.1.3      China Botulinum Toxin Market, By Gender

11.4.6.1.4      China Botulinum Toxin Market, By Age Group

11.4.6.1.5      China Botulinum Toxin Market, By End-User

11.4.6.2      Japan

11.4.6.2.1      Japan Botulinum Toxin Market, By Product Type

11.4.6.2.2      Japan Botulinum Toxin Market, By Application

11.4.6.2.2.1. Japan Therapeutic Market, By Application

11.4.6.2.3      Japan Botulinum Toxin Market, By Gender

11.4.6.2.4      Japan Botulinum Toxin Market, By Age Group

11.4.6.2.5      Japan Botulinum Toxin Market, By End-User

11.4.6.3      India

11.4.6.3.1      India Botulinum Toxin Market, By Product Type

11.4.6.3.2      India Botulinum Toxin Market, By Application

11.4.6.3.2.1. India Therapeutic Market, By Application

11.4.6.3.3      India Botulinum Toxin Market, By Gender

11.4.6.3.4      India Botulinum Toxin Market, By Age Group

11.4.6.3.5      India Botulinum Toxin Market, By End-User

11.4.6.4      Australia

11.4.6.4.1      Australia Botulinum Toxin Market, By Product Type

11.4.6.4.2      Australia Botulinum Toxin Market, By Application

11.4.6.4.2.1. Australia Therapeutic Market, By Application

11.4.6.4.3      Australia Botulinum Toxin Market, By Gender

11.4.6.4.4      Australia Botulinum Toxin Market, By Age Group

11.4.6.4.5      Australia Botulinum Toxin Market, By End-User

11.4.6.5      South Korea

11.4.6.5.1      South Korea Botulinum Toxin Market, By Product Type

11.4.6.5.2      South Korea Botulinum Toxin Market, By Application

11.4.6.5.2.1. South Korea Therapeutic Market, By Application

11.4.6.5.3      South Korea Botulinum Toxin Market, By Gender

11.4.6.5.4      South Korea Botulinum Toxin Market, By Age Group

11.4.6.5.5      South Korea Botulinum Toxin Market, By End-User

11.4.6.6      Taiwan

11.4.6.6.1      Taiwan Botulinum Toxin Market, By Product Type

11.4.6.6.2      Taiwan Botulinum Toxin Market, By Application

11.4.6.6.2.1. Taiwan Therapeutic Market, By Application

11.4.6.6.3      Taiwan Botulinum Toxin Market, By Gender

11.4.6.6.4      Taiwan Botulinum Toxin Market, By Age Group

11.4.6.6.5      Taiwan Botulinum Toxin Market, By End-User

11.4.6.7      Vietnam

11.4.6.7.1      Vietnam Botulinum Toxin Market, By Product Type

11.4.6.7.2      Vietnam Botulinum Toxin Market, By Application

11.4.6.7.2.1. Vietnam Therapeutic Market, By Application

11.4.6.7.3      Vietnam Botulinum Toxin Market, By Gender

11.4.6.7.4      Vietnam Botulinum Toxin Market, By Age Group

11.4.6.7.5      Vietnam Botulinum Toxin Market, By End-User

11.4.6.8      Rest of Asia-Pacific

11.4.6.8.1      Rest of Asia-Pacific Botulinum Toxin Market, By Product Type

11.4.6.8.2      Rest of Asia-Pacific Botulinum Toxin Market, By Application

11.4.6.8.2.1. Rest of Asia-Pacific Therapeutic Market, By Application

11.4.6.8.3      Rest of Asia-Pacific Botulinum Toxin Market, By Gender

11.4.6.8.4      Rest of Asia-Pacific Botulinum Toxin Market, By Age Group

11.4.6.8.5      Rest of Asia-Pacific Botulinum Toxin Market, By End-User

11.5.         Rest of World

11.5.1           Rest of World Botulinum Toxin Market, By Product Type

11.5.2           Rest of World Botulinum Toxin Market, By Application

11.5.2.1      Rest of World Therapeutic Market, By Application

11.5.3           Rest of World Botulinum Toxin Market, By Gender

11.5.4           Rest of World Botulinum Toxin Market, By Age Group

11.5.5           Rest of World Botulinum Toxin Market, By End-User

11.5.6           Rest of World Botulinum Toxin Market, By Country

11.5.6.1      Latin America

11.5.6.1.1      Latin America Botulinum Toxin Market, By Product Type

11.5.6.1.2      Latin America Botulinum Toxin Market, By Application

11.5.6.1.2.1. Latin America Therapeutic Market, By Application

11.5.6.1.3      Latin America Botulinum Toxin Market, By Gender

11.5.6.1.4      Latin America Botulinum Toxin Market, By Age Group

11.5.6.1.5      Latin America Botulinum Toxin Market, By End-User

11.5.6.2      Middle East

11.5.6.2.1      Middle East Botulinum Toxin Market, By Product Type

11.5.6.2.2      Middle East Botulinum Toxin Market, By Application

11.5.6.2.2.1. Middle East Therapeutic Market, By Application

11.5.6.2.3      Middle East Botulinum Toxin Market, By Gender

11.5.6.2.4      Middle East Botulinum Toxin Market, By Age Group

11.5.6.2.5      Middle East Botulinum Toxin Market, By End-User

11.5.6.3      Africa

11.5.6.3.1      Africa Botulinum Toxin Market, By Product Type

11.5.6.3.2      Africa Botulinum Toxin Market, By Application

11.5.6.3.2.1. Africa Therapeutic Market, By Application

11.5.6.3.3      Africa Botulinum Toxin Market, By Gender

11.5.6.3.4      Africa Botulinum Toxin Market, By Age Group

11.5.6.3.5      Africa Botulinum Toxin Market, By End-User

12.. COMPANY PROFILES

12.1.         Abbvie Inc.

12.1.1           Company overview

12.1.2           Company snapshot

12.1.3           Product Portfolio

12.1.4           Business performance

12.1.5           Sales by Geographic segment

12.1.6           Key strategic moves & developments

12.1.7           Primary Market Competitors

12.2.         EISAI CO., LTD.

12.2.1           Company overview

12.2.2           Company snapshot

12.2.3           Operating business segments

12.2.4           Product Portfolio

12.2.5           Business performance

12.2.6           Sales by Business segment

12.2.7           Sales by Geographic segment

12.2.8           Key strategic moves & developments

12.2.9           Primary Market Competitors

12.3.         Evolus Inc.

12.3.1           Company overview

12.3.2           Company snapshot

12.3.3           Product Portfolio

12.3.4           Business performance

12.3.5           Key strategic moves & developments

12.3.6           Primary Market Competitors

12.4.         GALDERMA

12.4.1           Company overview

12.4.2           Company snapshot

12.4.3           Product Portfolio

12.4.4           Key strategic moves & developments

12.4.5           Primary Market Competitors

12.5.         HUGEL, Inc.

12.5.1           Company overview

12.5.2           Company snapshot

12.5.3           Product Portfolio

12.5.4           Business performance

12.5.5           Key strategic moves & developments

12.5.6           Primary Market Competitors

12.6.         Revance Therapeutics Inc.

12.6.1           Company overview

12.6.2           Company snapshot

12.6.3           Operating business segments

12.6.4           Product Portfolio

12.6.5           Business performance

12.6.6           Sales by Business segment

12.6.7           Key strategic moves & developments

12.6.8           Primary Market Competitors

12.7.         Ipsen Pharma

12.7.1           Company overview

12.7.2           Company snapshot

12.7.3           Product Portfolio

12.7.4           Business performance

12.7.5           Key strategic moves & developments

12.7.6           Primary Market Competitors

12.8.         Merz Pharma GmbH & Co. KGaA

12.8.1           Company overview

12.8.2           Company snapshot

12.8.3           Product Portfolio

12.8.4           Key strategic moves & developments

12.8.5           Primary Market Competitors

12.9.         US WorldMeds LLC

12.9.1           Company overview

12.9.2           Company snapshot

12.9.3           Product Portfolio

12.9.4           Key strategic moves & developments

12.9.5           Primary Market Competitors

12.10.       MEDYTOX INC.

12.10.1         Company overview

12.10.2         Company snapshot

12.10.3         Product Portfolio

12.10.4         Key strategic moves & developments

12.10.5         Primary Market Competitors

12.11.       SUN PHARMACEUTICAL INDUSTRIES LIMITED

12.11.1         Company overview

12.11.2         Company snapshot

12.11.3         Product Portfolio

12.11.4         Business performance

12.11.5         Sales by Business segment

12.11.6         Sales by Geographic segment

12.11.7         Key strategic moves & developments

12.11.8         Primary Market Competitors

LIST OF TABLES

TABLE 1.       Global Botulinum Toxin Market Value, By Product Type, 2020-2025, Million USD

TABLE 2.       Global Botulinum Toxin Market Value, By Product Type, 2026-2030, Million USD

TABLE 3.       Toxin Type A Market Value, By Region, 2020-2025, Million USD

TABLE 4.       Toxin Type A Market Value, By Region, 2026-2030, Million USD

TABLE 5.       North America Toxin Type A Market Value, By Country, 2020-2025, Million USD

TABLE 6.       North America Toxin Type A Market Value, By Country, 2026-2030, Million USD

TABLE 7.       Europe Toxin Type A Market Value, By Country, 2020-2025, Million USD

TABLE 8.       Europe Toxin Type A Market Value, By Country, 2026-2030, Million USD

TABLE 9.       Asia-Pacific Toxin Type A Market Value, By Country, 2020-2025, Million USD

TABLE 10.    Asia-Pacific Toxin Type A Market Value, By Country, 2026-2030, Million USD

TABLE 11.    Rest of World Toxin Type A Market Value, By Country, 2020-2025, Million USD

TABLE 12.    Rest of World Toxin Type A Market Value, By Country, 2026-2030, Million USD

TABLE 13.    Toxin Type B Market Value, By Region, 2020-2025, Million USD

TABLE 14.    Toxin Type B Market Value, By Region, 2026-2030, Million USD

TABLE 15.    North America Toxin Type B Market Value, By Country, 2020-2025, Million USD

TABLE 16.    North America Toxin Type B Market Value, By Country, 2026-2030, Million USD

TABLE 17.    Europe Toxin Type B Market Value, By Country, 2020-2025, Million USD

TABLE 18.    Europe Toxin Type B Market Value, By Country, 2026-2030, Million USD

TABLE 19.    Asia-Pacific Toxin Type B Market Value, By Country, 2020-2025, Million USD

TABLE 20.    Asia-Pacific Toxin Type B Market Value, By Country, 2026-2030, Million USD

TABLE 21.    Rest of World Toxin Type B Market Value, By Country, 2020-2025, Million USD

TABLE 22.    Rest of World Toxin Type B Market Value, By Country, 2026-2030, Million USD

TABLE 23.    Global Botulinum Toxin Market Value, By Application, 2020-2025, Million USD

TABLE 24.    Global Botulinum Toxin Market Value, By Application, 2026-2030, Million USD

TABLE 25.    Global Therapeutic Market Value, By Application, 2020-2025, Million USD

TABLE 26.    Global Therapeutic Market Value, By Application, 2026-2030, Million USD

TABLE 27.    Chronic Migraine Market Value, By Region, 2020-2025, Million USD

TABLE 28.    Chronic Migraine Market Value, By Region, 2026-2030, Million USD

TABLE 29.    North America Chronic Migraine Market Value, By Country, 2020-2025, Million USD

TABLE 30.    North America Chronic Migraine Market Value, By Country, 2026-2030, Million USD

TABLE 31.    Europe Chronic Migraine Market Value, By Country, 2020-2025, Million USD

TABLE 32.    Europe Chronic Migraine Market Value, By Country, 2026-2030, Million USD

TABLE 33.    Asia-Pacific Chronic Migraine Market Value, By Country, 2020-2025, Million USD

TABLE 34.    Asia-Pacific Chronic Migraine Market Value, By Country, 2026-2030, Million USD

TABLE 35.    Rest of World Chronic Migraine Market Value, By Country, 2020-2025, Million USD

TABLE 36.    Rest of World Chronic Migraine Market Value, By Country, 2026-2030, Million USD

TABLE 37.    Spasticity Market Value, By Region, 2020-2025, Million USD

TABLE 38.    Spasticity Market Value, By Region, 2026-2030, Million USD

TABLE 39.    North America Spasticity Market Value, By Country, 2020-2025, Million USD

TABLE 40.    North America Spasticity Market Value, By Country, 2026-2030, Million USD

TABLE 41.    Europe Spasticity Market Value, By Country, 2020-2025, Million USD

TABLE 42.    Europe Spasticity Market Value, By Country, 2026-2030, Million USD

TABLE 43.    Asia-Pacific Spasticity Market Value, By Country, 2020-2025, Million USD

TABLE 44.    Asia-Pacific Spasticity Market Value, By Country, 2026-2030, Million USD

TABLE 45.    Rest of World Spasticity Market Value, By Country, 2020-2025, Million USD

TABLE 46.    Rest of World Spasticity Market Value, By Country, 2026-2030, Million USD

TABLE 47.    Overactive Bladder Market Value, By Region, 2020-2025, Million USD

TABLE 48.    Overactive Bladder Market Value, By Region, 2026-2030, Million USD

TABLE 49.    North America Overactive Bladder Market Value, By Country, 2020-2025, Million USD

TABLE 50.    North America Overactive Bladder Market Value, By Country, 2026-2030, Million USD

TABLE 51.    Europe Overactive Bladder Market Value, By Country, 2020-2025, Million USD

TABLE 52.    Europe Overactive Bladder Market Value, By Country, 2026-2030, Million USD

TABLE 53.    Asia-Pacific Overactive Bladder Market Value, By Country, 2020-2025, Million USD

TABLE 54.    Asia-Pacific Overactive Bladder Market Value, By Country, 2026-2030, Million USD

TABLE 55.    Rest of World Overactive Bladder Market Value, By Country, 2020-2025, Million USD

TABLE 56.    Rest of World Overactive Bladder Market Value, By Country, 2026-2030, Million USD

TABLE 57.    Cervical Dystonia Market Value, By Region, 2020-2025, Million USD

TABLE 58.    Cervical Dystonia Market Value, By Region, 2026-2030, Million USD

TABLE 59.    North America Cervical Dystonia Market Value, By Country, 2020-2025, Million USD

TABLE 60.    North America Cervical Dystonia Market Value, By Country, 2026-2030, Million USD

TABLE 61.    Europe Cervical Dystonia Market Value, By Country, 2020-2025, Million USD

TABLE 62.    Europe Cervical Dystonia Market Value, By Country, 2026-2030, Million USD

TABLE 63.    Asia-Pacific Cervical Dystonia Market Value, By Country, 2020-2025, Million USD

TABLE 64.    Asia-Pacific Cervical Dystonia Market Value, By Country, 2026-2030, Million USD

TABLE 65.    Rest of World Cervical Dystonia Market Value, By Country, 2020-2025, Million USD

TABLE 66.    Rest of World Cervical Dystonia Market Value, By Country, 2026-2030, Million USD

TABLE 67.    Blepharospasm Market Value, By Region, 2020-2025, Million USD

TABLE 68.    Blepharospasm Market Value, By Region, 2026-2030, Million USD

TABLE 69.    North America Blepharospasm Market Value, By Country, 2020-2025, Million USD

TABLE 70.    North America Blepharospasm Market Value, By Country, 2026-2030, Million USD

TABLE 71.    Europe Blepharospasm Market Value, By Country, 2020-2025, Million USD

TABLE 72.    Europe Blepharospasm Market Value, By Country, 2026-2030, Million USD

TABLE 73.    Asia-Pacific Blepharospasm Market Value, By Country, 2020-2025, Million USD

TABLE 74.    Asia-Pacific Blepharospasm Market Value, By Country, 2026-2030, Million USD

TABLE 75.    Rest of World Blepharospasm Market Value, By Country, 2020-2025, Million USD

TABLE 76.    Rest of World Blepharospasm Market Value, By Country, 2026-2030, Million USD

TABLE 77.    Axillary Hyperhidrosis Market Value, By Region, 2020-2025, Million USD

TABLE 78.    Axillary Hyperhidrosis Market Value, By Region, 2026-2030, Million USD

TABLE 79.    North America Axillary Hyperhidrosis Market Value, By Country, 2020-2025, Million USD

TABLE 80.    North America Axillary Hyperhidrosis Market Value, By Country, 2026-2030, Million USD

TABLE 81.    Europe Axillary Hyperhidrosis Market Value, By Country, 2020-2025, Million USD

TABLE 82.    Europe Axillary Hyperhidrosis Market Value, By Country, 2026-2030, Million USD

TABLE 83.    Asia-Pacific Axillary Hyperhidrosis Market Value, By Country, 2020-2025, Million USD

TABLE 84.    Asia-Pacific Axillary Hyperhidrosis Market Value, By Country, 2026-2030, Million USD

TABLE 85.    Rest of World Axillary Hyperhidrosis Market Value, By Country, 2020-2025, Million USD

TABLE 86.    Rest of World Axillary Hyperhidrosis Market Value, By Country, 2026-2030, Million USD

TABLE 87.    Others Market Value, By Region, 2020-2025, Million USD

TABLE 88.    Others Market Value, By Region, 2026-2030, Million USD

TABLE 89.    North America Others Market Value, By Country, 2020-2025, Million USD

TABLE 90.    North America Others Market Value, By Country, 2026-2030, Million USD

TABLE 91.    Europe Others Market Value, By Country, 2020-2025, Million USD

TABLE 92.    Europe Others Market Value, By Country, 2026-2030, Million USD

TABLE 93.    Asia-Pacific Others Market Value, By Country, 2020-2025, Million USD

TABLE 94.    Asia-Pacific Others Market Value, By Country, 2026-2030, Million USD

TABLE 95.    Rest of World Others Market Value, By Country, 2020-2025, Million USD

TABLE 96.    Rest of World Others Market Value, By Country, 2026-2030, Million USD

TABLE 97.    Therapeutic Market Value, By Region, 2020-2025, Million USD

TABLE 98.    Therapeutic Market Value, By Region, 2026-2030, Million USD

TABLE 99.    North America Therapeutic Market Value, By Country, 2020-2025, Million USD

TABLE 100.  North America Therapeutic Market Value, By Country, 2026-2030, Million USD

TABLE 101.  Europe Therapeutic Market Value, By Country, 2020-2025, Million USD

TABLE 102.  Europe Therapeutic Market Value, By Country, 2026-2030, Million USD

TABLE 103.  Asia-Pacific Therapeutic Market Value, By Country, 2020-2025, Million USD

TABLE 104.  Asia-Pacific Therapeutic Market Value, By Country, 2026-2030, Million USD

TABLE 105.  Rest of World Therapeutic Market Value, By Country, 2020-2025, Million USD

TABLE 106.  Rest of World Therapeutic Market Value, By Country, 2026-2030, Million USD

TABLE 107.  Aesthetic Market Value, By Region, 2020-2025, Million USD

TABLE 108.  Aesthetic Market Value, By Region, 2026-2030, Million USD

TABLE 109.  North America Aesthetic Market Value, By Country, 2020-2025, Million USD

TABLE 110.  North America Aesthetic Market Value, By Country, 2026-2030, Million USD

TABLE 111.  Europe Aesthetic Market Value, By Country, 2020-2025, Million USD

TABLE 112.  Europe Aesthetic Market Value, By Country, 2026-2030, Million USD

TABLE 113.  Asia-Pacific Aesthetic Market Value, By Country, 2020-2025, Million USD

TABLE 114.  Asia-Pacific Aesthetic Market Value, By Country, 2026-2030, Million USD

TABLE 115.  Rest of World Aesthetic Market Value, By Country, 2020-2025, Million USD

TABLE 116.  Rest of World Aesthetic Market Value, By Country, 2026-2030, Million USD

TABLE 117.  Global Botulinum Toxin Market Value, By Gender, 2020-2025, Million USD

TABLE 118.  Global Botulinum Toxin Market Value, By Gender, 2026-2030, Million USD

TABLE 119.  Male Market Value, By Region, 2020-2025, Million USD

TABLE 120.  Male Market Value, By Region, 2026-2030, Million USD

TABLE 121.  North America Male Market Value, By Country, 2020-2025, Million USD

TABLE 122.  North America Male Market Value, By Country, 2026-2030, Million USD

TABLE 123.  Europe Male Market Value, By Country, 2020-2025, Million USD

TABLE 124.  Europe Male Market Value, By Country, 2026-2030, Million USD

TABLE 125.  Asia-Pacific Male Market Value, By Country, 2020-2025, Million USD

TABLE 126.  Asia-Pacific Male Market Value, By Country, 2026-2030, Million USD

TABLE 127.  Rest of World Male Market Value, By Country, 2020-2025, Million USD

TABLE 128.  Rest of World Male Market Value, By Country, 2026-2030, Million USD

TABLE 129.  Female Market Value, By Region, 2020-2025, Million USD

TABLE 130.  Female Market Value, By Region, 2026-2030, Million USD

TABLE 131.  North America Female Market Value, By Country, 2020-2025, Million USD

TABLE 132.  North America Female Market Value, By Country, 2026-2030, Million USD

TABLE 133.  Europe Female Market Value, By Country, 2020-2025, Million USD

TABLE 134.  Europe Female Market Value, By Country, 2026-2030, Million USD

TABLE 135.  Asia-Pacific Female Market Value, By Country, 2020-2025, Million USD

TABLE 136.  Asia-Pacific Female Market Value, By Country, 2026-2030, Million USD

TABLE 137.  Rest of World Female Market Value, By Country, 2020-2025, Million USD

TABLE 138.  Rest of World Female Market Value, By Country, 2026-2030, Million USD

TABLE 139.  Global Botulinum Toxin Market Value, By Age Group, 2020-2025, Million USD

TABLE 140.  Global Botulinum Toxin Market Value, By Age Group, 2026-2030, Million USD

TABLE 141.-19 Market Value, By Region, 2020-2025, Million USD

TABLE 142.-19 Market Value, By Region, 2026-2030, Million USD

TABLE 143.  North America 13-19 Market Value, By Country, 2020-2025, Million USD

TABLE 144.  North America 13-19 Market Value, By Country, 2026-2030, Million USD

TABLE 145.  Europe 13-19 Market Value, By Country, 2020-2025, Million USD

TABLE 146.  Europe 13-19 Market Value, By Country, 2026-2030, Million USD

TABLE 147.  Asia-Pacific 13-19 Market Value, By Country, 2020-2025, Million USD

TABLE 148.  Asia-Pacific 13-19 Market Value, By Country, 2026-2030, Million USD

TABLE 149.  Rest of World 13-19 Market Value, By Country, 2020-2025, Million USD

TABLE 150.  Rest of World 13-19 Market Value, By Country, 2026-2030, Million USD

TABLE 151.-29 Market Value, By Region, 2020-2025, Million USD

TABLE 152.-29 Market Value, By Region, 2026-2030, Million USD

TABLE 153.  North America 20-29 Market Value, By Country, 2020-2025, Million USD

TABLE 154.  North America 20-29 Market Value, By Country, 2026-2030, Million USD

TABLE 155.  Europe 20-29 Market Value, By Country, 2020-2025, Million USD

TABLE 156.  Europe 20-29 Market Value, By Country, 2026-2030, Million USD

TABLE 157.  Asia-Pacific 20-29 Market Value, By Country, 2020-2025, Million USD

TABLE 158.  Asia-Pacific 20-29 Market Value, By Country, 2026-2030, Million USD

TABLE 159.  Rest of World 20-29 Market Value, By Country, 2020-2025, Million USD

TABLE 160.  Rest of World 20-29 Market Value, By Country, 2026-2030, Million USD

TABLE 161.-39 Market Value, By Region, 2020-2025, Million USD

TABLE 162.-39 Market Value, By Region, 2026-2030, Million USD

TABLE 163.  North America 30-39 Market Value, By Country, 2020-2025, Million USD

TABLE 164.  North America 30-39 Market Value, By Country, 2026-2030, Million USD

TABLE 165.  Europe 30-39 Market Value, By Country, 2020-2025, Million USD

TABLE 166.  Europe 30-39 Market Value, By Country, 2026-2030, Million USD

TABLE 167.  Asia-Pacific 30-39 Market Value, By Country, 2020-2025, Million USD

TABLE 168.  Asia-Pacific 30-39 Market Value, By Country, 2026-2030, Million USD

TABLE 169.  Rest of World 30-39 Market Value, By Country, 2020-2025, Million USD

TABLE 170.  Rest of World 30-39 Market Value, By Country, 2026-2030, Million USD

TABLE 171.-54 Market Value, By Region, 2020-2025, Million USD

TABLE 172.-54 Market Value, By Region, 2026-2030, Million USD

TABLE 173.  North America 40-54 Market Value, By Country, 2020-2025, Million USD

TABLE 174.  North America 40-54 Market Value, By Country, 2026-2030, Million USD

TABLE 175.  Europe 40-54 Market Value, By Country, 2020-2025, Million USD

TABLE 176.  Europe 40-54 Market Value, By Country, 2026-2030, Million USD

TABLE 177.  Asia-Pacific 40-54 Market Value, By Country, 2020-2025, Million USD

TABLE 178.  Asia-Pacific 40-54 Market Value, By Country, 2026-2030, Million USD

TABLE 179.  Rest of World 40-54 Market Value, By Country, 2020-2025, Million USD

TABLE 180.  Rest of World 40-54 Market Value, By Country, 2026-2030, Million USD

TABLE 181. and above Market Value, By Region, 2020-2025, Million USD

TABLE 182. and above Market Value, By Region, 2026-2030, Million USD

TABLE 183.  North America 55 and above Market Value, By Country, 2020-2025, Million USD

TABLE 184.  North America 55 and above Market Value, By Country, 2026-2030, Million USD

TABLE 185.  Europe 55 and above Market Value, By Country, 2020-2025, Million USD

TABLE 186.  Europe 55 and above Market Value, By Country, 2026-2030, Million USD

TABLE 187.  Asia-Pacific 55 and above Market Value, By Country, 2020-2025, Million USD

TABLE 188.  Asia-Pacific 55 and above Market Value, By Country, 2026-2030, Million USD

TABLE 189.  Rest of World 55 and above Market Value, By Country, 2020-2025, Million USD

TABLE 190.  Rest of World 55 and above Market Value, By Country, 2026-2030, Million USD

TABLE 191.  Global Botulinum Toxin Market Value, By End-User, 2020-2025, Million USD

TABLE 192.  Global Botulinum Toxin Market Value, By End-User, 2026-2030, Million USD

TABLE 193.  Hospitals Market Value, By Region, 2020-2025, Million USD

TABLE 194.  Hospitals Market Value, By Region, 2026-2030, Million USD

TABLE 195.  North America Hospitals Market Value, By Country, 2020-2025, Million USD

TABLE 196.  North America Hospitals Market Value, By Country, 2026-2030, Million USD

TABLE 197.  Europe Hospitals Market Value, By Country, 2020-2025, Million USD

TABLE 198.  Europe Hospitals Market Value, By Country, 2026-2030, Million USD

TABLE 199.  Asia-Pacific Hospitals Market Value, By Country, 2020-2025, Million USD

TABLE 200.  Asia-Pacific Hospitals Market Value, By Country, 2026-2030, Million USD

TABLE 201.  Rest of World Hospitals Market Value, By Country, 2020-2025, Million USD

TABLE 202.  Rest of World Hospitals Market Value, By Country, 2026-2030, Million USD

TABLE 203.  Dermatology Clinics Market Value, By Region, 2020-2025, Million USD

TABLE 204.  Dermatology Clinics Market Value, By Region, 2026-2030, Million USD

TABLE 205.  North America Dermatology Clinics Market Value, By Country, 2020-2025, Million USD

TABLE 206.  North America Dermatology Clinics Market Value, By Country, 2026-2030, Million USD

TABLE 207.  Europe Dermatology Clinics Market Value, By Country, 2020-2025, Million USD

TABLE 208.  Europe Dermatology Clinics Market Value, By Country, 2026-2030, Million USD

TABLE 209.  Asia-Pacific Dermatology Clinics Market Value, By Country, 2020-2025, Million USD

TABLE 210.  Asia-Pacific Dermatology Clinics Market Value, By Country, 2026-2030, Million USD

TABLE 211.  Rest of World Dermatology Clinics Market Value, By Country, 2020-2025, Million USD

TABLE 212.  Rest of World Dermatology Clinics Market Value, By Country, 2026-2030, Million USD

TABLE 213.  Spas & Cosmetic Centers Market Value, By Region, 2020-2025, Million USD

TABLE 214.  Spas & Cosmetic Centers Market Value, By Region, 2026-2030, Million USD

TABLE 215.  North America Spas & Cosmetic Centers Market Value, By Country, 2020-2025, Million USD

TABLE 216.  North America Spas & Cosmetic Centers Market Value, By Country, 2026-2030, Million USD

TABLE 217.  Europe Spas & Cosmetic Centers Market Value, By Country, 2020-2025, Million USD

TABLE 218.  Europe Spas & Cosmetic Centers Market Value, By Country, 2026-2030, Million USD

TABLE 219.  Asia-Pacific Spas & Cosmetic Centers Market Value, By Country, 2020-2025, Million USD

TABLE 220.  Asia-Pacific Spas & Cosmetic Centers Market Value, By Country, 2026-2030, Million USD

TABLE 221.  Rest of World Spas & Cosmetic Centers Market Value, By Country, 2020-2025, Million USD

TABLE 222.  Rest of World Spas & Cosmetic Centers Market Value, By Country, 2026-2030, Million USD

TABLE 223.  Global Botulinum Toxin Market Value, By Region, 2020-2025, Million USD

TABLE 224.  Global Botulinum Toxin Market Value, By Region, 2026-2030, Million USD

TABLE 225.  North America Botulinum Toxin Market Value, By Product Type, 2020-2025, Million USD

TABLE 226.  North America Botulinum Toxin Market Value, By Product Type, 2026-2030, Million USD

TABLE 227.  North America Botulinum Toxin Market Value, By Application, 2020-2025, Million USD

TABLE 228.  North America Botulinum Toxin Market Value, By Application, 2026-2030, Million USD

TABLE 229.  North America Therapeutic Market Value, By Application, 2020-2025, Million USD

TABLE 230.  North America Therapeutic Market Value, By Application, 2026-2030, Million USD

TABLE 231.  North America Botulinum Toxin Market Value, By Gender, 2020-2025, Million USD

TABLE 232.  North America Botulinum Toxin Market Value, By Gender, 2026-2030, Million USD

TABLE 233.  North America Botulinum Toxin Market Value, By Age Group, 2020-2025, Million USD

TABLE 234.  North America Botulinum Toxin Market Value, By Age Group, 2026-2030, Million USD

TABLE 235.  North America Botulinum Toxin Market Value, By End-User, 2020-2025, Million USD

TABLE 236.  North America Botulinum Toxin Market Value, By End-User, 2026-2030, Million USD

TABLE 237.  North America Botulinum Toxin Market Value, By Country, 2020-2025, Million USD

TABLE 238.  North America Botulinum Toxin Market Value, By Country, 2026-2030, Million USD

TABLE 239.  U.S. Botulinum Toxin Market Value, By Product Type, 2020-2025, Million USD

TABLE 240.  U.S. Botulinum Toxin Market Value, By Product Type, 2026-2030, Million USD

TABLE 241.  U.S. Botulinum Toxin Market Value, By Application, 2020-2025, Million USD

TABLE 242.  U.S. Botulinum Toxin Market Value, By Application, 2026-2030, Million USD

TABLE 243.  U.S. Therapeutic Market Value, By Application, 2020-2025, Million USD

TABLE 244.  U.S. Therapeutic Market Value, By Application, 2026-2030, Million USD

TABLE 245.  U.S. Botulinum Toxin Market Value, By Gender, 2020-2025, Million USD

TABLE 246.  U.S. Botulinum Toxin Market Value, By Gender, 2026-2030, Million USD

TABLE 247.  U.S. Botulinum Toxin Market Value, By Age Group, 2020-2025, Million USD

TABLE 248.  U.S. Botulinum Toxin Market Value, By Age Group, 2026-2030, Million USD

TABLE 249.  U.S. Botulinum Toxin Market Value, By End-User, 2020-2025, Million USD

TABLE 250.  U.S. Botulinum Toxin Market Value, By End-User, 2026-2030, Million USD

TABLE 251.  Canada Botulinum Toxin Market Value, By Product Type, 2020-2025, Million USD

TABLE 252.  Canada Botulinum Toxin Market Value, By Product Type, 2026-2030, Million USD

TABLE 253.  Canada Botulinum Toxin Market Value, By Application, 2020-2025, Million USD

TABLE 254.  Canada Botulinum Toxin Market Value, By Application, 2026-2030, Million USD

TABLE 255.  Canada Therapeutic Market Value, By Application, 2020-2025, Million USD

TABLE 256.  Canada Therapeutic Market Value, By Application, 2026-2030, Million USD

TABLE 257.  Canada Botulinum Toxin Market Value, By Gender, 2020-2025, Million USD

TABLE 258.  Canada Botulinum Toxin Market Value, By Gender, 2026-2030, Million USD

TABLE 259.  Canada Botulinum Toxin Market Value, By Age Group, 2020-2025, Million USD

TABLE 260.  Canada Botulinum Toxin Market Value, By Age Group, 2026-2030, Million USD

TABLE 261.  Canada Botulinum Toxin Market Value, By End-User, 2020-2025, Million USD

TABLE 262.  Canada Botulinum Toxin Market Value, By End-User, 2026-2030, Million USD

TABLE 263.  Mexico Botulinum Toxin Market Value, By Product Type, 2020-2025, Million USD

TABLE 264.  Mexico Botulinum Toxin Market Value, By Product Type, 2026-2030, Million USD

TABLE 265.  Mexico Botulinum Toxin Market Value, By Application, 2020-2025, Million USD

TABLE 266.  Mexico Botulinum Toxin Market Value, By Application, 2026-2030, Million USD

TABLE 267.  Mexico Therapeutic Market Value, By Application, 2020-2025, Million USD

TABLE 268.  Mexico Therapeutic Market Value, By Application, 2026-2030, Million USD

TABLE 269.  Mexico Botulinum Toxin Market Value, By Gender, 2020-2025, Million USD

TABLE 270.  Mexico Botulinum Toxin Market Value, By Gender, 2026-2030, Million USD

TABLE 271.  Mexico Botulinum Toxin Market Value, By Age Group, 2020-2025, Million USD

TABLE 272.  Mexico Botulinum Toxin Market Value, By Age Group, 2026-2030, Million USD

TABLE 273.  Mexico Botulinum Toxin Market Value, By End-User, 2020-2025, Million USD

TABLE 274.  Mexico Botulinum Toxin Market Value, By End-User, 2026-2030, Million USD

TABLE 275.  Europe Botulinum Toxin Market Value, By Product Type, 2020-2025, Million USD

TABLE 276.  Europe Botulinum Toxin Market Value, By Product Type, 2026-2030, Million USD

TABLE 277.  Europe Botulinum Toxin Market Value, By Application, 2020-2025, Million USD

TABLE 278.  Europe Botulinum Toxin Market Value, By Application, 2026-2030, Million USD

TABLE 279.  Europe Therapeutic Market Value, By Application, 2020-2025, Million USD

TABLE 280.  Europe Therapeutic Market Value, By Application, 2026-2030, Million USD

TABLE 281.  Europe Botulinum Toxin Market Value, By Gender, 2020-2025, Million USD

TABLE 282.  Europe Botulinum Toxin Market Value, By Gender, 2026-2030, Million USD

TABLE 283.  Europe Botulinum Toxin Market Value, By Age Group, 2020-2025, Million USD

TABLE 284.  Europe Botulinum Toxin Market Value, By Age Group, 2026-2030, Million USD

TABLE 285.  Europe Botulinum Toxin Market Value, By End-User, 2020-2025, Million USD

TABLE 286.  Europe Botulinum Toxin Market Value, By End-User, 2026-2030, Million USD

TABLE 287.  Europe Botulinum Toxin Market Value, By Country, 2020-2025, Million USD

TABLE 288.  Europe Botulinum Toxin Market Value, By Country, 2026-2030, Million USD

TABLE 289.  UK Botulinum Toxin Market Value, By Product Type, 2020-2025, Million USD

TABLE 290.  UK Botulinum Toxin Market Value, By Product Type, 2026-2030, Million USD

TABLE 291.  UK Botulinum Toxin Market Value, By Application, 2020-2025, Million USD

TABLE 292.  UK Botulinum Toxin Market Value, By Application, 2026-2030, Million USD

TABLE 293.  UK Therapeutic Market Value, By Application, 2020-2025, Million USD

TABLE 294.  UK Therapeutic Market Value, By Application, 2026-2030, Million USD

TABLE 295.  UK Botulinum Toxin Market Value, By Gender, 2020-2025, Million USD

TABLE 296.  UK Botulinum Toxin Market Value, By Gender, 2026-2030, Million USD

TABLE 297.  UK Botulinum Toxin Market Value, By Age Group, 2020-2025, Million USD

TABLE 298.  UK Botulinum Toxin Market Value, By Age Group, 2026-2030, Million USD

TABLE 299.  UK Botulinum Toxin Market Value, By End-User, 2020-2025, Million USD

TABLE 300.  UK Botulinum Toxin Market Value, By End-User, 2026-2030, Million USD

TABLE 301.  Germany Botulinum Toxin Market Value, By Product Type, 2020-2025, Million USD

TABLE 302.  Germany Botulinum Toxin Market Value, By Product Type, 2026-2030, Million USD

TABLE 303.  Germany Botulinum Toxin Market Value, By Application, 2020-2025, Million USD

TABLE 304.  Germany Botulinum Toxin Market Value, By Application, 2026-2030, Million USD

TABLE 305.  Germany Therapeutic Market Value, By Application, 2020-2025, Million USD

TABLE 306.  Germany Therapeutic Market Value, By Application, 2026-2030, Million USD

TABLE 307.  Germany Botulinum Toxin Market Value, By Gender, 2020-2025, Million USD

TABLE 308.  Germany Botulinum Toxin Market Value, By Gender, 2026-2030, Million USD

TABLE 309.  Germany Botulinum Toxin Market Value, By Age Group, 2020-2025, Million USD

TABLE 310.  Germany Botulinum Toxin Market Value, By Age Group, 2026-2030, Million USD

TABLE 311.  Germany Botulinum Toxin Market Value, By End-User, 2020-2025, Million USD

TABLE 312.  Germany Botulinum Toxin Market Value, By End-User, 2026-2030, Million USD

TABLE 313.  France Botulinum Toxin Market Value, By Product Type, 2020-2025, Million USD

TABLE 314.  France Botulinum Toxin Market Value, By Product Type, 2026-2030, Million USD

TABLE 315.  France Botulinum Toxin Market Value, By Application, 2020-2025, Million USD

TABLE 316.  France Botulinum Toxin Market Value, By Application, 2026-2030, Million USD

TABLE 317.  France Therapeutic Market Value, By Application, 2020-2025, Million USD

TABLE 318.  France Therapeutic Market Value, By Application, 2026-2030, Million USD

TABLE 319.  France Botulinum Toxin Market Value, By Gender, 2020-2025, Million USD

TABLE 320.  France Botulinum Toxin Market Value, By Gender, 2026-2030, Million USD

TABLE 321.  France Botulinum Toxin Market Value, By Age Group, 2020-2025, Million USD

TABLE 322.  France Botulinum Toxin Market Value, By Age Group, 2026-2030, Million USD

TABLE 323.  France Botulinum Toxin Market Value, By End-User, 2020-2025, Million USD

TABLE 324.  France Botulinum Toxin Market Value, By End-User, 2026-2030, Million USD

TABLE 325.  Spain Botulinum Toxin Market Value, By Product Type, 2020-2025, Million USD

TABLE 326.  Spain Botulinum Toxin Market Value, By Product Type, 2026-2030, Million USD

TABLE 327.  Spain Botulinum Toxin Market Value, By Application, 2020-2025, Million USD

TABLE 328.  Spain Botulinum Toxin Market Value, By Application, 2026-2030, Million USD

TABLE 329.  Spain Therapeutic Market Value, By Application, 2020-2025, Million USD

TABLE 330.  Spain Therapeutic Market Value, By Application, 2026-2030, Million USD

TABLE 331.  Spain Botulinum Toxin Market Value, By Gender, 2020-2025, Million USD

TABLE 332.  Spain Botulinum Toxin Market Value, By Gender, 2026-2030, Million USD

TABLE 333.  Spain Botulinum Toxin Market Value, By Age Group, 2020-2025, Million USD

TABLE 334.  Spain Botulinum Toxin Market Value, By Age Group, 2026-2030, Million USD

TABLE 335.  Spain Botulinum Toxin Market Value, By End-User, 2020-2025, Million USD

TABLE 336.  Spain Botulinum Toxin Market Value, By End-User, 2026-2030, Million USD

TABLE 337.  Italy Botulinum Toxin Market Value, By Product Type, 2020-2025, Million USD

TABLE 338.  Italy Botulinum Toxin Market Value, By Product Type, 2026-2030, Million USD

TABLE 339.  Italy Botulinum Toxin Market Value, By Application, 2020-2025, Million USD

TABLE 340.  Italy Botulinum Toxin Market Value, By Application, 2026-2030, Million USD

TABLE 341.  Italy Therapeutic Market Value, By Application, 2020-2025, Million USD

TABLE 342.  Italy Therapeutic Market Value, By Application, 2026-2030, Million USD

TABLE 343.  Italy Botulinum Toxin Market Value, By Gender, 2020-2025, Million USD

TABLE 344.  Italy Botulinum Toxin Market Value, By Gender, 2026-2030, Million USD

TABLE 345.  Italy Botulinum Toxin Market Value, By Age Group, 2020-2025, Million USD

TABLE 346.  Italy Botulinum Toxin Market Value, By Age Group, 2026-2030, Million USD

TABLE 347.  Italy Botulinum Toxin Market Value, By End-User, 2020-2025, Million USD

TABLE 348.  Italy Botulinum Toxin Market Value, By End-User, 2026-2030, Million USD

TABLE 349.  Netherlands Botulinum Toxin Market Value, By Product Type, 2020-2025, Million USD

TABLE 350.  Netherlands Botulinum Toxin Market Value, By Product Type, 2026-2030, Million USD

TABLE 351.  Netherlands Botulinum Toxin Market Value, By Application, 2020-2025, Million USD

TABLE 352.  Netherlands Botulinum Toxin Market Value, By Application, 2026-2030, Million USD

TABLE 353.  Netherlands Therapeutic Market Value, By Application, 2020-2025, Million USD

TABLE 354.  Netherlands Therapeutic Market Value, By Application, 2026-2030, Million USD

TABLE 355.  Netherlands Botulinum Toxin Market Value, By Gender, 2020-2025, Million USD

TABLE 356.  Netherlands Botulinum Toxin Market Value, By Gender, 2026-2030, Million USD

TABLE 357.  Netherlands Botulinum Toxin Market Value, By Age Group, 2020-2025, Million USD

TABLE 358.  Netherlands Botulinum Toxin Market Value, By Age Group, 2026-2030, Million USD

TABLE 359.  Netherlands Botulinum Toxin Market Value, By End-User, 2020-2025, Million USD

TABLE 360.  Netherlands Botulinum Toxin Market Value, By End-User, 2026-2030, Million USD

TABLE 361.  Rest of Europe Botulinum Toxin Market Value, By Product Type, 2020-2025, Million USD

TABLE 362.  Rest of Europe Botulinum Toxin Market Value, By Product Type, 2026-2030, Million USD

TABLE 363.  Rest of Europe Botulinum Toxin Market Value, By Application, 2020-2025, Million USD

TABLE 364.  Rest of Europe Botulinum Toxin Market Value, By Application, 2026-2030, Million USD

TABLE 365.  Rest of Europe Therapeutic Market Value, By Application, 2020-2025, Million USD

TABLE 366.  Rest of Europe Therapeutic Market Value, By Application, 2026-2030, Million USD

TABLE 367.  Rest of Europe Botulinum Toxin Market Value, By Gender, 2020-2025, Million USD

TABLE 368.  Rest of Europe Botulinum Toxin Market Value, By Gender, 2026-2030, Million USD

TABLE 369.  Rest of Europe Botulinum Toxin Market Value, By Age Group, 2020-2025, Million USD

TABLE 370.  Rest of Europe Botulinum Toxin Market Value, By Age Group, 2026-2030, Million USD

TABLE 371.  Rest of Europe Botulinum Toxin Market Value, By End-User, 2020-2025, Million USD

TABLE 372.  Rest of Europe Botulinum Toxin Market Value, By End-User, 2026-2030, Million USD

TABLE 373.  Asia-Pacific Botulinum Toxin Market Value, By Product Type, 2020-2025, Million USD

TABLE 374.  Asia-Pacific Botulinum Toxin Market Value, By Product Type, 2026-2030, Million USD

TABLE 375.  Asia-Pacific Botulinum Toxin Market Value, By Application, 2020-2025, Million USD

TABLE 376.  Asia-Pacific Botulinum Toxin Market Value, By Application, 2026-2030, Million USD

TABLE 377.  Asia-Pacific Therapeutic Market Value, By Application, 2020-2025, Million USD

TABLE 378.  Asia-Pacific Therapeutic Market Value, By Application, 2026-2030, Million USD

TABLE 379.  Asia-Pacific Botulinum Toxin Market Value, By Gender, 2020-2025, Million USD

TABLE 380.  Asia-Pacific Botulinum Toxin Market Value, By Gender, 2026-2030, Million USD

TABLE 381.  Asia-Pacific Botulinum Toxin Market Value, By Age Group, 2020-2025, Million USD

TABLE 382.  Asia-Pacific Botulinum Toxin Market Value, By Age Group, 2026-2030, Million USD

TABLE 383.  Asia-Pacific Botulinum Toxin Market Value, By End-User, 2020-2025, Million USD

TABLE 384.  Asia-Pacific Botulinum Toxin Market Value, By End-User, 2026-2030, Million USD

TABLE 385.  Asia-Pacific Botulinum Toxin Market Value, By Country, 2020-2025, Million USD

TABLE 386.  Asia-Pacific Botulinum Toxin Market Value, By Country, 2026-2030, Million USD

TABLE 387.  China Botulinum Toxin Market Value, By Product Type, 2020-2025, Million USD

TABLE 388.  China Botulinum Toxin Market Value, By Product Type, 2026-2030, Million USD

TABLE 389.  China Botulinum Toxin Market Value, By Application, 2020-2025, Million USD

TABLE 390.  China Botulinum Toxin Market Value, By Application, 2026-2030, Million USD

TABLE 391.  China Therapeutic Market Value, By Application, 2020-2025, Million USD

TABLE 392.  China Therapeutic Market Value, By Application, 2026-2030, Million USD

TABLE 393.  China Botulinum Toxin Market Value, By Gender, 2020-2025, Million USD

TABLE 394.  China Botulinum Toxin Market Value, By Gender, 2026-2030, Million USD

TABLE 395.  China Botulinum Toxin Market Value, By Age Group, 2020-2025, Million USD

TABLE 396.  China Botulinum Toxin Market Value, By Age Group, 2026-2030, Million USD

TABLE 397.  China Botulinum Toxin Market Value, By End-User, 2020-2025, Million USD

TABLE 398.  China Botulinum Toxin Market Value, By End-User, 2026-2030, Million USD

TABLE 399.  Japan Botulinum Toxin Market Value, By Product Type, 2020-2025, Million USD

TABLE 400.  Japan Botulinum Toxin Market Value, By Product Type, 2026-2030, Million USD

TABLE 401.  Japan Botulinum Toxin Market Value, By Application, 2020-2025, Million USD

TABLE 402.  Japan Botulinum Toxin Market Value, By Application, 2026-2030, Million USD

TABLE 403.  Japan Therapeutic Market Value, By Application, 2020-2025, Million USD

TABLE 404.  Japan Therapeutic Market Value, By Application, 2026-2030, Million USD

TABLE 405.  Japan Botulinum Toxin Market Value, By Gender, 2020-2025, Million USD

TABLE 406.  Japan Botulinum Toxin Market Value, By Gender, 2026-2030, Million USD

TABLE 407.  Japan Botulinum Toxin Market Value, By Age Group, 2020-2025, Million USD

TABLE 408.  Japan Botulinum Toxin Market Value, By Age Group, 2026-2030, Million USD

TABLE 409.  Japan Botulinum Toxin Market Value, By End-User, 2020-2025, Million USD

TABLE 410.  Japan Botulinum Toxin Market Value, By End-User, 2026-2030, Million USD

TABLE 411.  India Botulinum Toxin Market Value, By Product Type, 2020-2025, Million USD

TABLE 412.  India Botulinum Toxin Market Value, By Product Type, 2026-2030, Million USD

TABLE 413.  India Botulinum Toxin Market Value, By Application, 2020-2025, Million USD

TABLE 414.  India Botulinum Toxin Market Value, By Application, 2026-2030, Million USD

TABLE 415.  India Therapeutic Market Value, By Application, 2020-2025, Million USD

TABLE 416.  India Therapeutic Market Value, By Application, 2026-2030, Million USD

TABLE 417.  India Botulinum Toxin Market Value, By Gender, 2020-2025, Million USD

TABLE 418.  India Botulinum Toxin Market Value, By Gender, 2026-2030, Million USD

TABLE 419.  India Botulinum Toxin Market Value, By Age Group, 2020-2025, Million USD

TABLE 420.  India Botulinum Toxin Market Value, By Age Group, 2026-2030, Million USD

TABLE 421.  India Botulinum Toxin Market Value, By End-User, 2020-2025, Million USD

TABLE 422.  India Botulinum Toxin Market Value, By End-User, 2026-2030, Million USD

TABLE 423.  Australia Botulinum Toxin Market Value, By Product Type, 2020-2025, Million USD

TABLE 424.  Australia Botulinum Toxin Market Value, By Product Type, 2026-2030, Million USD

TABLE 425.  Australia Botulinum Toxin Market Value, By Application, 2020-2025, Million USD

TABLE 426.  Australia Botulinum Toxin Market Value, By Application, 2026-2030, Million USD

TABLE 427.  Australia Therapeutic Market Value, By Application, 2020-2025, Million USD

TABLE 428.  Australia Therapeutic Market Value, By Application, 2026-2030, Million USD

TABLE 429.  Australia Botulinum Toxin Market Value, By Gender, 2020-2025, Million USD

TABLE 430.  Australia Botulinum Toxin Market Value, By Gender, 2026-2030, Million USD

TABLE 431.  Australia Botulinum Toxin Market Value, By Age Group, 2020-2025, Million USD

TABLE 432.  Australia Botulinum Toxin Market Value, By Age Group, 2026-2030, Million USD

TABLE 433.  Australia Botulinum Toxin Market Value, By End-User, 2020-2025, Million USD

TABLE 434.  Australia Botulinum Toxin Market Value, By End-User, 2026-2030, Million USD

TABLE 435.  South Korea Botulinum Toxin Market Value, By Product Type, 2020-2025, Million USD

TABLE 436.  South Korea Botulinum Toxin Market Value, By Product Type, 2026-2030, Million USD

TABLE 437.  South Korea Botulinum Toxin Market Value, By Application, 2020-2025, Million USD

TABLE 438.  South Korea Botulinum Toxin Market Value, By Application, 2026-2030, Million USD

TABLE 439.  South Korea Therapeutic Market Value, By Application, 2020-2025, Million USD

TABLE 440.  South Korea Therapeutic Market Value, By Application, 2026-2030, Million USD

TABLE 441.  South Korea Botulinum Toxin Market Value, By Gender, 2020-2025, Million USD

TABLE 442.  South Korea Botulinum Toxin Market Value, By Gender, 2026-2030, Million USD

TABLE 443.  South Korea Botulinum Toxin Market Value, By Age Group, 2020-2025, Million USD

TABLE 444.  South Korea Botulinum Toxin Market Value, By Age Group, 2026-2030, Million USD

TABLE 445.  South Korea Botulinum Toxin Market Value, By End-User, 2020-2025, Million USD

TABLE 446.  South Korea Botulinum Toxin Market Value, By End-User, 2026-2030, Million USD

TABLE 447.  Taiwan Botulinum Toxin Market Value, By Product Type, 2020-2025, Million USD

TABLE 448.  Taiwan Botulinum Toxin Market Value, By Product Type, 2026-2030, Million USD

TABLE 449.  Taiwan Botulinum Toxin Market Value, By Application, 2020-2025, Million USD

TABLE 450.  Taiwan Botulinum Toxin Market Value, By Application, 2026-2030, Million USD

TABLE 451.  Taiwan Therapeutic Market Value, By Application, 2020-2025, Million USD

TABLE 452.  Taiwan Therapeutic Market Value, By Application, 2026-2030, Million USD

TABLE 453.  Taiwan Botulinum Toxin Market Value, By Gender, 2020-2025, Million USD

TABLE 454.  Taiwan Botulinum Toxin Market Value, By Gender, 2026-2030, Million USD

TABLE 455.  Taiwan Botulinum Toxin Market Value, By Age Group, 2020-2025, Million USD

TABLE 456.  Taiwan Botulinum Toxin Market Value, By Age Group, 2026-2030, Million USD

TABLE 457.  Taiwan Botulinum Toxin Market Value, By End-User, 2020-2025, Million USD

TABLE 458.  Taiwan Botulinum Toxin Market Value, By End-User, 2026-2030, Million USD

TABLE 459.  Vietnam Botulinum Toxin Market Value, By Product Type, 2020-2025, Million USD

TABLE 460.  Vietnam Botulinum Toxin Market Value, By Product Type, 2026-2030, Million USD

TABLE 461.  Vietnam Botulinum Toxin Market Value, By Application, 2020-2025, Million USD

TABLE 462.  Vietnam Botulinum Toxin Market Value, By Application, 2026-2030, Million USD

TABLE 463.  Vietnam Therapeutic Market Value, By Application, 2020-2025, Million USD

TABLE 464.  Vietnam Therapeutic Market Value, By Application, 2026-2030, Million USD

TABLE 465.  Vietnam Botulinum Toxin Market Value, By Gender, 2020-2025, Million USD

TABLE 466.  Vietnam Botulinum Toxin Market Value, By Gender, 2026-2030, Million USD

TABLE 467.  Vietnam Botulinum Toxin Market Value, By Age Group, 2020-2025, Million USD

TABLE 468.  Vietnam Botulinum Toxin Market Value, By Age Group, 2026-2030, Million USD

TABLE 469.  Vietnam Botulinum Toxin Market Value, By End-User, 2020-2025, Million USD

TABLE 470.  Vietnam Botulinum Toxin Market Value, By End-User, 2026-2030, Million USD

TABLE 471.  Rest of Asia-Pacific Botulinum Toxin Market Value, By Product Type, 2020-2025, Million USD

TABLE 472.  Rest of Asia-Pacific Botulinum Toxin Market Value, By Product Type, 2026-2030, Million USD

TABLE 473.  Rest of Asia-Pacific Botulinum Toxin Market Value, By Application, 2020-2025, Million USD

TABLE 474.  Rest of Asia-Pacific Botulinum Toxin Market Value, By Application, 2026-2030, Million USD

TABLE 475.  Rest of Asia-Pacific Therapeutic Market Value, By Application, 2020-2025, Million USD

TABLE 476.  Rest of Asia-Pacific Therapeutic Market Value, By Application, 2026-2030, Million USD

TABLE 477.  Rest of Asia-Pacific Botulinum Toxin Market Value, By Gender, 2020-2025, Million USD

TABLE 478.  Rest of Asia-Pacific Botulinum Toxin Market Value, By Gender, 2026-2030, Million USD

TABLE 479.  Rest of Asia-Pacific Botulinum Toxin Market Value, By Age Group, 2020-2025, Million USD

TABLE 480.  Rest of Asia-Pacific Botulinum Toxin Market Value, By Age Group, 2026-2030, Million USD

TABLE 481.  Rest of Asia-Pacific Botulinum Toxin Market Value, By End-User, 2020-2025, Million USD

TABLE 482.  Rest of Asia-Pacific Botulinum Toxin Market Value, By End-User, 2026-2030, Million USD

TABLE 483.  Rest of World Botulinum Toxin Market Value, By Product Type, 2020-2025, Million USD

TABLE 484.  Rest of World Botulinum Toxin Market Value, By Product Type, 2026-2030, Million USD

TABLE 485.  Rest of World Botulinum Toxin Market Value, By Application, 2020-2025, Million USD

TABLE 486.  Rest of World Botulinum Toxin Market Value, By Application, 2026-2030, Million USD

TABLE 487.  Rest of World Therapeutic Market Value, By Application, 2020-2025, Million USD

TABLE 488.  Rest of World Therapeutic Market Value, By Application, 2026-2030, Million USD

TABLE 489.  Rest of World Botulinum Toxin Market Value, By Gender, 2020-2025, Million USD

TABLE 490.  Rest of World Botulinum Toxin Market Value, By Gender, 2026-2030, Million USD

TABLE 491.  Rest of World Botulinum Toxin Market Value, By Age Group, 2020-2025, Million USD

TABLE 492.  Rest of World Botulinum Toxin Market Value, By Age Group, 2026-2030, Million USD

TABLE 493.  Rest of World Botulinum Toxin Market Value, By End-User, 2020-2025, Million USD

TABLE 494.  Rest of World Botulinum Toxin Market Value, By End-User, 2026-2030, Million USD

TABLE 495.  Rest of World Botulinum Toxin Market Value, By Country, 2020-2025, Million USD

TABLE 496.  Rest of World Botulinum Toxin Market Value, By Country, 2026-2030, Million USD

TABLE 497.  Latin America Botulinum Toxin Market Value, By Product Type, 2020-2025, Million USD

TABLE 498.  Latin America Botulinum Toxin Market Value, By Product Type, 2026-2030, Million USD

TABLE 499.  Latin America Botulinum Toxin Market Value, By Application, 2020-2025, Million USD

TABLE 500.  Latin America Botulinum Toxin Market Value, By Application, 2026-2030, Million USD

TABLE 501.  Latin America Therapeutic Market Value, By Application, 2020-2025, Million USD

TABLE 502.  Latin America Therapeutic Market Value, By Application, 2026-2030, Million USD

TABLE 503.  Latin America Botulinum Toxin Market Value, By Gender, 2020-2025, Million USD

TABLE 504.  Latin America Botulinum Toxin Market Value, By Gender, 2026-2030, Million USD

TABLE 505.  Latin America Botulinum Toxin Market Value, By Age Group, 2020-2025, Million USD

TABLE 506.  Latin America Botulinum Toxin Market Value, By Age Group, 2026-2030, Million USD

TABLE 507.  Latin America Botulinum Toxin Market Value, By End-User, 2020-2025, Million USD

TABLE 508.  Latin America Botulinum Toxin Market Value, By End-User, 2026-2030, Million USD

TABLE 509.  Middle East Botulinum Toxin Market Value, By Product Type, 2020-2025, Million USD

TABLE 510.  Middle East Botulinum Toxin Market Value, By Product Type, 2026-2030, Million USD

TABLE 511.  Middle East Botulinum Toxin Market Value, By Application, 2020-2025, Million USD

TABLE 512.  Middle East Botulinum Toxin Market Value, By Application, 2026-2030, Million USD

TABLE 513.  Middle East Therapeutic Market Value, By Application, 2020-2025, Million USD

TABLE 514.  Middle East Therapeutic Market Value, By Application, 2026-2030, Million USD

TABLE 515.  Middle East Botulinum Toxin Market Value, By Gender, 2020-2025, Million USD

TABLE 516.  Middle East Botulinum Toxin Market Value, By Gender, 2026-2030, Million USD

TABLE 517.  Middle East Botulinum Toxin Market Value, By Age Group, 2020-2025, Million USD

TABLE 518.  Middle East Botulinum Toxin Market Value, By Age Group, 2026-2030, Million USD

TABLE 519.  Middle East Botulinum Toxin Market Value, By End-User, 2020-2025, Million USD

TABLE 520.  Middle East Botulinum Toxin Market Value, By End-User, 2026-2030, Million USD

TABLE 521.  Africa Botulinum Toxin Market Value, By Product Type, 2020-2025, Million USD

TABLE 522.  Africa Botulinum Toxin Market Value, By Product Type, 2026-2030, Million USD

TABLE 523.  Africa Botulinum Toxin Market Value, By Application, 2020-2025, Million USD

TABLE 524.  Africa Botulinum Toxin Market Value, By Application, 2026-2030, Million USD

TABLE 525.  Africa Therapeutic Market Value, By Application, 2020-2025, Million USD

TABLE 526.  Africa Therapeutic Market Value, By Application, 2026-2030, Million USD

TABLE 527.  Africa Botulinum Toxin Market Value, By Gender, 2020-2025, Million USD

TABLE 528.  Africa Botulinum Toxin Market Value, By Gender, 2026-2030, Million USD

TABLE 529.  Africa Botulinum Toxin Market Value, By Age Group, 2020-2025, Million USD

TABLE 530.  Africa Botulinum Toxin Market Value, By Age Group, 2026-2030, Million USD

TABLE 531.  Africa Botulinum Toxin Market Value, By End-User, 2020-2025, Million USD

TABLE 532.  Africa Botulinum Toxin Market Value, By End-User, 2026-2030, Million USD

TABLE 533.  ABBVIE INC.: COMPANY SNAPSHOT

TABLE 534.  ABBVIE INC.: Product Portfolio

TABLE 535.  EISAI CO., LTD.: COMPANY SNAPSHOT

TABLE 536.  Eisai Co., Ltd..: Product Portfolio

TABLE 537.  Eisai Co., Ltd..: Product Portfolio

TABLE 538.  EVOLUS INC.: COMPANY SNAPSHOT

TABLE 539.  Evolus Inc.: Product Portfolio

TABLE 540.  GALDERMA: COMPANY SNAPSHOT

TABLE 541.  GALDERMA.: Product Portfolio

TABLE 542.  HUGEL, INC.: COMPANY SNAPSHOT

TABLE 543.  HUGEL, Inc..: Product Portfolio

TABLE 544.  REVANCE THERAPEUTICS INC.: COMPANY SNAPSHOT

TABLE 545.  REVANCE THERAPEUTICS INC. : operating segments

TABLE 546.  REVANCE THERAPEUTICS INC.: Product Portfolio

TABLE 547.  IPSEN PHARMA: COMPANY SNAPSHOT

TABLE 548.  IPSEN PHARMA: Product Portfolio

TABLE 549.  Merz Pharma GmbH & Co. KGaA: COMPANY SNAPSHOT

TABLE 550.  Merz Pharma GmbH & Co. KGaA: Product Portfolio

TABLE 551.  US WorldMeds LLC: COMPANY SNAPSHOT

TABLE 552.  US WorldMeds LLC: Product Portfolio

TABLE 553.  MEDYTOX INC.: COMPANY SNAPSHOT

TABLE 554.  MEDYTOX INC.: Product Portfolio

TABLE 555.  SUN PHARMACEUTICAL INDUSTRIES LIMITED: COMPANY SNAPSHOT

TABLE 556.  SUN PHARMACEUTICAL INDUSTRIES LIMITED: Product Portfolio

TABLE 557.  Sun Pharmaceutical Industries Limited: Business segment

 

 

LIST OF FIGURES

FIGURE 1.     Market share analysis of top Acne medication PROVIDERS, 2020

FIGURE 2.     Global Botulinum Toxin Market Value, By Product Type, 2020-2030, Million USD

FIGURE 3.     Toxin Type A Market Value, By Region, 2020-2030, Million USD

FIGURE 4.     North America Toxin Type A Market Value, By Country, 2020-2030, Million USD

FIGURE 5.     Europe Toxin Type A Market Value, By Country, 2020-2030, Million USD

FIGURE 6.     Asia-Pacific Toxin Type A Market Value, By Country, 2020-2030, Million USD

FIGURE 7.     Rest of World Toxin Type A Market Value, By Country, 2020-2030, Million USD

FIGURE 8.     Toxin Type B Market Value, By Region, 2020-2030, Million USD

FIGURE 9.     North America Toxin Type B Market Value, By Country, 2020-2030, Million USD

FIGURE 10.  Europe Toxin Type B Market Value, By Country, 2020-2030, Million USD

FIGURE 11.  Asia-Pacific Toxin Type B Market Value, By Country, 2020-2030, Million USD

FIGURE 12.  Rest of World Toxin Type B Market Value, By Country, 2020-2030, Million USD

FIGURE 13.  Global Botulinum Toxin Market Value, By Application, 2020-2030, Million USD

FIGURE 14.  Global Therapeutic Market Value, By Application, 2020-2030, Million USD

FIGURE 15.  Chronic Migraine Market Value, By Region, 2020-2030, Million USD

FIGURE 16.  North America Chronic Migraine Market Value, By Country, 2020-2030, Million USD

FIGURE 17.  Europe Chronic Migraine Market Value, By Country, 2020-2030, Million USD

FIGURE 18.  Asia-Pacific Chronic Migraine Market Value, By Country, 2020-2030, Million USD

FIGURE 19.  Rest of World Chronic Migraine Market Value, By Country, 2020-2030, Million USD

FIGURE 20.  Spasticity Market Value, By Region, 2020-2030, Million USD

FIGURE 21.  North America Spasticity Market Value, By Country, 2020-2030, Million USD

FIGURE 22.  Europe Spasticity Market Value, By Country, 2020-2030, Million USD

FIGURE 23.  Asia-Pacific Spasticity Market Value, By Country, 2020-2030, Million USD

FIGURE 24.  Rest of World Spasticity Market Value, By Country, 2020-2030, Million USD

FIGURE 25.  Overactive Bladder Market Value, By Region, 2020-2030, Million USD

FIGURE 26.  North America Overactive Bladder Market Value, By Country, 2020-2030, Million USD

FIGURE 27.  Europe Overactive Bladder Market Value, By Country, 2020-2030, Million USD

FIGURE 28.  Asia-Pacific Overactive Bladder Market Value, By Country, 2020-2030, Million USD

FIGURE 29.  Rest of World Overactive Bladder Market Value, By Country, 2020-2030, Million USD

FIGURE 30.  Cervical Dystonia Market Value, By Region, 2020-2030, Million USD

FIGURE 31.  North America Cervical Dystonia Market Value, By Country, 2020-2030, Million USD

FIGURE 32.  Europe Cervical Dystonia Market Value, By Country, 2020-2030, Million USD

FIGURE 33.  Asia-Pacific Cervical Dystonia Market Value, By Country, 2020-2030, Million USD

FIGURE 34.  Rest of World Cervical Dystonia Market Value, By Country, 2020-2030, Million USD

FIGURE 35.  Blepharospasm Market Value, By Region, 2020-2030, Million USD

FIGURE 36.  North America Blepharospasm Market Value, By Country, 2020-2030, Million USD

FIGURE 37.  Europe Blepharospasm Market Value, By Country, 2020-2030, Million USD

FIGURE 38.  Asia-Pacific Blepharospasm Market Value, By Country, 2020-2030, Million USD

FIGURE 39.  Rest of World Blepharospasm Market Value, By Country, 2020-2030, Million USD

FIGURE 40.  Axillary Hyperhidrosis Market Value, By Region, 2020-2030, Million USD

FIGURE 41.  North America Axillary Hyperhidrosis Market Value, By Country, 2020-2030, Million USD

FIGURE 42.  Europe Axillary Hyperhidrosis Market Value, By Country, 2020-2030, Million USD

FIGURE 43.  Asia-Pacific Axillary Hyperhidrosis Market Value, By Country, 2020-2030, Million USD

FIGURE 44.  Rest of World Axillary Hyperhidrosis Market Value, By Country, 2020-2030, Million USD

FIGURE 45.  Others Market Value, By Region, 2020-2030, Million USD

FIGURE 46.  North America Others Market Value, By Country, 2020-2030, Million USD

FIGURE 47.  Europe Others Market Value, By Country, 2020-2030, Million USD

FIGURE 48.  Asia-Pacific Others Market Value, By Country, 2020-2030, Million USD

FIGURE 49.  Rest of World Others Market Value, By Country, 2020-2030, Million USD

FIGURE 50.  Therapeutic Market Value, By Region, 2020-2030, Million USD

FIGURE 51.  North America Therapeutic Market Value, By Country, 2020-2030, Million USD

FIGURE 52.  Europe Therapeutic Market Value, By Country, 2020-2030, Million USD

FIGURE 53.  Asia-Pacific Therapeutic Market Value, By Country, 2020-2030, Million USD

FIGURE 54.  Rest of World Therapeutic Market Value, By Country, 2020-2030, Million USD

FIGURE 55.  Aesthetic Market Value, By Region, 2020-2030, Million USD

FIGURE 56.  North America Aesthetic Market Value, By Country, 2020-2030, Million USD

FIGURE 57.  Europe Aesthetic Market Value, By Country, 2020-2030, Million USD

FIGURE 58.  Asia-Pacific Aesthetic Market Value, By Country, 2020-2030, Million USD

FIGURE 59.  Rest of World Aesthetic Market Value, By Country, 2020-2030, Million USD

FIGURE 60.  Global Botulinum Toxin Market Value, By Gender, 2020-2030, Million USD

FIGURE 61.  Male Market Value, By Region, 2020-2030, Million USD

FIGURE 62.  North America Male Market Value, By Country, 2020-2030, Million USD

FIGURE 63.  Europe Male Market Value, By Country, 2020-2030, Million USD

FIGURE 64.  Asia-Pacific Male Market Value, By Country, 2020-2030, Million USD

FIGURE 65.  Rest of World Male Market Value, By Country, 2020-2030, Million USD

FIGURE 66.  Female Market Value, By Region, 2020-2030, Million USD

FIGURE 67.  North America Female Market Value, By Country, 2020-2030, Million USD

FIGURE 68.  Europe Female Market Value, By Country, 2020-2030, Million USD

FIGURE 69.  Asia-Pacific Female Market Value, By Country, 2020-2030, Million USD

FIGURE 70.  Rest of World Female Market Value, By Country, 2020-2030, Million USD

FIGURE 71.  Global Botulinum Toxin Market Value, By Age Group, 2020-2030, Million USD

FIGURE 72.-19 Market Value, By Region, 2020-2030, Million USD

FIGURE 73.  North America 13-19 Market Value, By Country, 2020-2030, Million USD

FIGURE 74.  Europe 13-19 Market Value, By Country, 2020-2030, Million USD

FIGURE 75.  Asia-Pacific 13-19 Market Value, By Country, 2020-2030, Million USD

FIGURE 76.  Rest of World 13-19 Market Value, By Country, 2020-2030, Million USD

FIGURE 77.-29 Market Value, By Region, 2020-2030, Million USD

FIGURE 78.  North America 20-29 Market Value, By Country, 2020-2030, Million USD

FIGURE 79.  Europe 20-29 Market Value, By Country, 2020-2030, Million USD

FIGURE 80.  Asia-Pacific 20-29 Market Value, By Country, 2020-2030, Million USD

FIGURE 81.  Rest of World 20-29 Market Value, By Country, 2020-2030, Million USD

FIGURE 82.-39 Market Value, By Region, 2020-2030, Million USD

FIGURE 83.  North America 30-39 Market Value, By Country, 2020-2030, Million USD

FIGURE 84.  Europe 30-39 Market Value, By Country, 2020-2030, Million USD

FIGURE 85.  Asia-Pacific 30-39 Market Value, By Country, 2020-2030, Million USD

FIGURE 86.  Rest of World 30-39 Market Value, By Country, 2020-2030, Million USD

FIGURE 87.-54 Market Value, By Region, 2020-2030, Million USD

FIGURE 88.  North America 40-54 Market Value, By Country, 2020-2030, Million USD

FIGURE 89.  Europe 40-54 Market Value, By Country, 2020-2030, Million USD

FIGURE 90.  Asia-Pacific 40-54 Market Value, By Country, 2020-2030, Million USD

FIGURE 91.  Rest of World 40-54 Market Value, By Country, 2020-2030, Million USD

FIGURE 92. and above Market Value, By Region, 2020-2030, Million USD

FIGURE 93.  North America 55 and above Market Value, By Country, 2020-2030, Million USD

FIGURE 94.  Europe 55 and above Market Value, By Country, 2020-2030, Million USD

FIGURE 95.  Asia-Pacific 55 and above Market Value, By Country, 2020-2030, Million USD

FIGURE 96.  Rest of World 55 and above Market Value, By Country, 2020-2030, Million USD

FIGURE 97.  Global Botulinum Toxin Market Value, By End-User, 2020-2030, Million USD

FIGURE 98.  Hospitals Market Value, By Region, 2020-2030, Million USD

FIGURE 99.  North America Hospitals Market Value, By Country, 2020-2030, Million USD

FIGURE 100.                        Europe Hospitals Market Value, By Country, 2020-2030, Million USD

FIGURE 101.                        Asia-Pacific Hospitals Market Value, By Country, 2020-2030, Million USD

FIGURE 102.                        Rest of World Hospitals Market Value, By Country, 2020-2030, Million USD

FIGURE 103.                        Dermatology Clinics Market Value, By Region, 2020-2030, Million USD

FIGURE 104.                        North America Dermatology Clinics Market Value, By Country, 2020-2030, Million USD

FIGURE 105.                        Europe Dermatology Clinics Market Value, By Country, 2020-2030, Million USD

FIGURE 106.                        Asia-Pacific Dermatology Clinics Market Value, By Country, 2020-2030, Million USD

FIGURE 107.                        Rest of World Dermatology Clinics Market Value, By Country, 2020-2030, Million USD

FIGURE 108.                        Spas & Cosmetic Centers Market Value, By Region, 2020-2030, Million USD

FIGURE 109.                        North America Spas & Cosmetic Centers Market Value, By Country, 2020-2030, Million USD

FIGURE 110.                        Europe Spas & Cosmetic Centers Market Value, By Country, 2020-2030, Million USD

FIGURE 111.                        Asia-Pacific Spas & Cosmetic Centers Market Value, By Country, 2020-2030, Million USD

FIGURE 112.                        Rest of World Spas & Cosmetic Centers Market Value, By Country, 2020-2030, Million USD

FIGURE 113.                        Global Botulinum Toxin Market Value, By Region, 2020-2030, Million USD

FIGURE 114.                        North America Botulinum Toxin Market Value, By Product Type, 2020-2030, Million USD

FIGURE 115.                        North America Botulinum Toxin Market Value, By Application, 2020-2030, Million USD

FIGURE 116.                        North America Therapeutic Market Value, By Application, 2020-2030, Million USD

FIGURE 117.                        North America Botulinum Toxin Market Value, By Gender, 2020-2030, Million USD

FIGURE 118.                        North America Botulinum Toxin Market Value, By Age Group, 2020-2030, Million USD

FIGURE 119.                        North America Botulinum Toxin Market Value, By End-User, 2020-2030, Million USD

FIGURE 120.                        North America Botulinum Toxin Market Value, By Country, 2020-2030, Million USD

FIGURE 121.                        U.S. Botulinum Toxin Market, By Product Type, 2020-2030, Million USD

FIGURE 122.                        U.S. Botulinum Toxin Market, By Application, 2020-2030, Million USD

FIGURE 123.                        U.S. Therapeutic Market Value, By Application, 2020-2030, Million USD

FIGURE 124.                        U.S. Botulinum Toxin Market, By Gender, 2020-2030, Million USD

FIGURE 125.                        U.S. Botulinum Toxin Market, By Age Group, 2020-2030, Million USD

FIGURE 126.                        U.S. Botulinum Toxin Market, By End-User, 2020-2030, Million USD

FIGURE 127.                        Canada Botulinum Toxin Market, By Product Type, 2020-2030, Million USD

FIGURE 128.                        Canada Botulinum Toxin Market, By Application, 2020-2030, Million USD

FIGURE 129.                        Canada Therapeutic Market Value, By Application, 2020-2030, Million USD

FIGURE 130.                        Canada Botulinum Toxin Market, By Gender, 2020-2030, Million USD

FIGURE 131.                        Canada Botulinum Toxin Market, By Age Group, 2020-2030, Million USD

FIGURE 132.                        Canada Botulinum Toxin Market, By End-User, 2020-2030, Million USD

FIGURE 133.                        Mexico Botulinum Toxin Market, By Product Type, 2020-2030, Million USD

FIGURE 134.                        Mexico Botulinum Toxin Market, By Application, 2020-2030, Million USD

FIGURE 135.                        Mexico Therapeutic Market Value, By Application, 2020-2030, Million USD

FIGURE 136.                        Mexico Botulinum Toxin Market, By Gender, 2020-2030, Million USD

FIGURE 137.                        Mexico Botulinum Toxin Market, By Age Group, 2020-2030, Million USD

FIGURE 138.                        Mexico Botulinum Toxin Market, By End-User, 2020-2030, Million USD

FIGURE 139.                        Europe Botulinum Toxin Market Value, By Product Type, 2020-2030, Million USD

FIGURE 140.                        Europe Botulinum Toxin Market Value, By Application, 2020-2030, Million USD

FIGURE 141.                        Europe Therapeutic Market Value, By Application, 2020-2030, Million USD

FIGURE 142.                        Europe Botulinum Toxin Market Value, By Gender, 2020-2030, Million USD

FIGURE 143.                        Europe Botulinum Toxin Market Value, By Age Group, 2020-2030, Million USD

FIGURE 144.                        Europe Botulinum Toxin Market Value, By End-User, 2020-2030, Million USD

FIGURE 145.                        Europe Botulinum Toxin Market Value, By Country, 2020-2030, Million USD

FIGURE 146.                        UK Botulinum Toxin Market, By Product Type, 2020-2030, Million USD

FIGURE 147.                        UK Botulinum Toxin Market, By Application, 2020-2030, Million USD

FIGURE 148.                        UK Therapeutic Market Value, By Application, 2020-2030, Million USD

FIGURE 149.                        UK Botulinum Toxin Market, By Gender, 2020-2030, Million USD

FIGURE 150.                        UK Botulinum Toxin Market, By Age Group, 2020-2030, Million USD

FIGURE 151.                        UK Botulinum Toxin Market, By End-User, 2020-2030, Million USD

FIGURE 152.                        Germany Botulinum Toxin Market, By Product Type, 2020-2030, Million USD

FIGURE 153.                        Germany Botulinum Toxin Market, By Application, 2020-2030, Million USD

FIGURE 154.                        Germany Therapeutic Market Value, By Application, 2020-2030, Million USD

FIGURE 155.                        Germany Botulinum Toxin Market, By Gender, 2020-2030, Million USD

FIGURE 156.                        Germany Botulinum Toxin Market, By Age Group, 2020-2030, Million USD

FIGURE 157.                        Germany Botulinum Toxin Market, By End-User, 2020-2030, Million USD

FIGURE 158.                        France Botulinum Toxin Market, By Product Type, 2020-2030, Million USD

FIGURE 159.                        France Botulinum Toxin Market, By Application, 2020-2030, Million USD

FIGURE 160.                        France Therapeutic Market Value, By Application, 2020-2030, Million USD

FIGURE 161.                        France Botulinum Toxin Market, By Gender, 2020-2030, Million USD

FIGURE 162.                        France Botulinum Toxin Market, By Age Group, 2020-2030, Million USD

FIGURE 163.                        France Botulinum Toxin Market, By End-User, 2020-2030, Million USD

FIGURE 164.                        Spain Botulinum Toxin Market, By Product Type, 2020-2030, Million USD

FIGURE 165.                        Spain Botulinum Toxin Market, By Application, 2020-2030, Million USD

FIGURE 166.                        Spain Therapeutic Market Value, By Application, 2020-2030, Million USD

FIGURE 167.                        Spain Botulinum Toxin Market, By Gender, 2020-2030, Million USD

FIGURE 168.                        Spain Botulinum Toxin Market, By Age Group, 2020-2030, Million USD

FIGURE 169.                        Spain Botulinum Toxin Market, By End-User, 2020-2030, Million USD

FIGURE 170.                        Italy Botulinum Toxin Market, By Product Type, 2020-2030, Million USD

FIGURE 171.                        Italy Botulinum Toxin Market, By Application, 2020-2030, Million USD

FIGURE 172.                        Italy Therapeutic Market Value, By Application, 2020-2030, Million USD

FIGURE 173.                        Italy Botulinum Toxin Market, By Gender, 2020-2030, Million USD

FIGURE 174.                        Italy Botulinum Toxin Market, By Age Group, 2020-2030, Million USD

FIGURE 175.                        Italy Botulinum Toxin Market, By End-User, 2020-2030, Million USD

FIGURE 176.                        Netherlands Botulinum Toxin Market, By Product Type, 2020-2030, Million USD

FIGURE 177.                        Netherlands Botulinum Toxin Market, By Application, 2020-2030, Million USD

FIGURE 178.                        Netherlands Therapeutic Market Value, By Application, 2020-2030, Million USD

FIGURE 179.                        Netherlands Botulinum Toxin Market, By Gender, 2020-2030, Million USD

FIGURE 180.                        Netherlands Botulinum Toxin Market, By Age Group, 2020-2030, Million USD

FIGURE 181.                        Netherlands Botulinum Toxin Market, By End-User, 2020-2030, Million USD

FIGURE 182.                        Rest of Europe Botulinum Toxin Market, By Product Type, 2020-2030, Million USD

FIGURE 183.                        Rest of Europe Botulinum Toxin Market, By Application, 2020-2030, Million USD

FIGURE 184.                        Rest of Europe Therapeutic Market Value, By Application, 2020-2030, Million USD

FIGURE 185.                        Rest of Europe Botulinum Toxin Market, By Gender, 2020-2030, Million USD

FIGURE 186.                        Rest of Europe Botulinum Toxin Market, By Age Group, 2020-2030, Million USD

FIGURE 187.                        Rest of Europe Botulinum Toxin Market, By End-User, 2020-2030, Million USD

FIGURE 188.                        Asia-Pacific Botulinum Toxin Market Value, By Product Type, 2020-2030, Million USD

FIGURE 189.                        Asia-Pacific Botulinum Toxin Market Value, By Application, 2020-2030, Million USD

FIGURE 190.                        Asia-Pacific Therapeutic Market Value, By Application, 2020-2030, Million USD

FIGURE 191.                        Asia-Pacific Botulinum Toxin Market Value, By Gender, 2020-2030, Million USD

FIGURE 192.                        Asia-Pacific Botulinum Toxin Market Value, By Age Group, 2020-2030, Million USD

FIGURE 193.                        Asia-Pacific Botulinum Toxin Market Value, By End-User, 2020-2030, Million USD

FIGURE 194.                        Asia-Pacific Botulinum Toxin Market Value, By Country, 2020-2030, Million USD

FIGURE 195.                        China Botulinum Toxin Market, By Product Type, 2020-2030, Million USD

FIGURE 196.                        China Botulinum Toxin Market, By Application, 2020-2030, Million USD

FIGURE 197.                        China Therapeutic Market Value, By Application, 2020-2030, Million USD

FIGURE 198.                        China Botulinum Toxin Market, By Gender, 2020-2030, Million USD

FIGURE 199.                        China Botulinum Toxin Market, By Age Group, 2020-2030, Million USD

FIGURE 200.                        China Botulinum Toxin Market, By End-User, 2020-2030, Million USD

FIGURE 201.                        Japan Botulinum Toxin Market, By Product Type, 2020-2030, Million USD

FIGURE 202.                        Japan Botulinum Toxin Market, By Application, 2020-2030, Million USD

FIGURE 203.                        Japan Therapeutic Market Value, By Application, 2020-2030, Million USD

FIGURE 204.                        Japan Botulinum Toxin Market, By Gender, 2020-2030, Million USD

FIGURE 205.                        Japan Botulinum Toxin Market, By Age Group, 2020-2030, Million USD

FIGURE 206.                        Japan Botulinum Toxin Market, By End-User, 2020-2030, Million USD

FIGURE 207.                        India Botulinum Toxin Market, By Product Type, 2020-2030, Million USD

FIGURE 208.                        India Botulinum Toxin Market, By Application, 2020-2030, Million USD

FIGURE 209.                        India Therapeutic Market Value, By Application, 2020-2030, Million USD

FIGURE 210.                        India Botulinum Toxin Market, By Gender, 2020-2030, Million USD

FIGURE 211.                        India Botulinum Toxin Market, By Age Group, 2020-2030, Million USD

FIGURE 212.                        India Botulinum Toxin Market, By End-User, 2020-2030, Million USD

FIGURE 213.                        Australia Botulinum Toxin Market, By Product Type, 2020-2030, Million USD

FIGURE 214.                        Australia Botulinum Toxin Market, By Application, 2020-2030, Million USD

FIGURE 215.                        Australia Therapeutic Market Value, By Application, 2020-2030, Million USD

FIGURE 216.                        Australia Botulinum Toxin Market, By Gender, 2020-2030, Million USD

FIGURE 217.                        Australia Botulinum Toxin Market, By Age Group, 2020-2030, Million USD

FIGURE 218.                        Australia Botulinum Toxin Market, By End-User, 2020-2030, Million USD

FIGURE 219.                        South Korea Botulinum Toxin Market, By Product Type, 2020-2030, Million USD

FIGURE 220.                        South Korea Botulinum Toxin Market, By Application, 2020-2030, Million USD

FIGURE 221.                        South Korea Therapeutic Market Value, By Application, 2020-2030, Million USD

FIGURE 222.                        South Korea Botulinum Toxin Market, By Gender, 2020-2030, Million USD

FIGURE 223.                        South Korea Botulinum Toxin Market, By Age Group, 2020-2030, Million USD

FIGURE 224.                        South Korea Botulinum Toxin Market, By End-User, 2020-2030, Million USD

FIGURE 225.                        Taiwan Botulinum Toxin Market, By Product Type, 2020-2030, Million USD

FIGURE 226.                        Taiwan Botulinum Toxin Market, By Application, 2020-2030, Million USD

FIGURE 227.                        Taiwan Therapeutic Market Value, By Application, 2020-2030, Million USD

FIGURE 228.                        Taiwan Botulinum Toxin Market, By Gender, 2020-2030, Million USD

FIGURE 229.                        Taiwan Botulinum Toxin Market, By Age Group, 2020-2030, Million USD

FIGURE 230.                        Taiwan Botulinum Toxin Market, By End-User, 2020-2030, Million USD

FIGURE 231.                        Vietnam Botulinum Toxin Market, By Product Type, 2020-2030, Million USD

FIGURE 232.                        Vietnam Botulinum Toxin Market, By Application, 2020-2030, Million USD

FIGURE 233.                        Vietnam Therapeutic Market Value, By Application, 2020-2030, Million USD

FIGURE 234.                        Vietnam Botulinum Toxin Market, By Gender, 2020-2030, Million USD

FIGURE 235.                        Vietnam Botulinum Toxin Market, By Age Group, 2020-2030, Million USD

FIGURE 236.                        Vietnam Botulinum Toxin Market, By End-User, 2020-2030, Million USD

FIGURE 237.                        Rest of Asia-Pacific Botulinum Toxin Market, By Product Type, 2020-2030, Million USD

FIGURE 238.                        Rest of Asia-Pacific Botulinum Toxin Market, By Application, 2020-2030, Million USD

FIGURE 239.                        Rest of Asia-Pacific Therapeutic Market Value, By Application, 2020-2030, Million USD

FIGURE 240.                        Rest of Asia-Pacific Botulinum Toxin Market, By Gender, 2020-2030, Million USD

FIGURE 241.                        Rest of Asia-Pacific Botulinum Toxin Market, By Age Group, 2020-2030, Million USD

FIGURE 242.                        Rest of Asia-Pacific Botulinum Toxin Market, By End-User, 2020-2030, Million USD

FIGURE 243.                        Rest of World Botulinum Toxin Market Value, By Product Type, 2020-2030, Million USD

FIGURE 244.                        Rest of World Botulinum Toxin Market Value, By Application, 2020-2030, Million USD

FIGURE 245.                        Rest of World Therapeutic Market Value, By Application, 2020-2030, Million USD

FIGURE 246.                        Rest of World Botulinum Toxin Market Value, By Gender, 2020-2030, Million USD

FIGURE 247.                        Rest of World Botulinum Toxin Market Value, By Age Group, 2020-2030, Million USD

FIGURE 248.                        Rest of World Botulinum Toxin Market Value, By End-User, 2020-2030, Million USD

FIGURE 249.                        Rest of World Botulinum Toxin Market Value, By Country, 2020-2030, Million USD

FIGURE 250.                        Latin America Botulinum Toxin Market, By Product Type, 2020-2030, Million USD

FIGURE 251.                        Latin America Botulinum Toxin Market, By Application, 2020-2030, Million USD

FIGURE 252.                        Latin America Therapeutic Market Value, By Application, 2020-2030, Million USD

FIGURE 253.                        Latin America Botulinum Toxin Market, By Gender, 2020-2030, Million USD

FIGURE 254.                        Latin America Botulinum Toxin Market, By Age Group, 2020-2030, Million USD

FIGURE 255.                        Latin America Botulinum Toxin Market, By End-User, 2020-2030, Million USD

FIGURE 256.                        Middle East Botulinum Toxin Market, By Product Type, 2020-2030, Million USD

FIGURE 257.                        Middle East Botulinum Toxin Market, By Application, 2020-2030, Million USD

FIGURE 258.                        Middle East Therapeutic Market Value, By Application, 2020-2030, Million USD

FIGURE 259.                        Middle East Botulinum Toxin Market, By Gender, 2020-2030, Million USD

FIGURE 260.                        Middle East Botulinum Toxin Market, By Age Group, 2020-2030, Million USD

FIGURE 261.                        Middle East Botulinum Toxin Market, By End-User, 2020-2030, Million USD

FIGURE 262.                        Africa Botulinum Toxin Market, By Product Type, 2020-2030, Million USD

FIGURE 263.                        Africa Botulinum Toxin Market, By Application, 2020-2030, Million USD

FIGURE 264.                        Africa Therapeutic Market Value, By Application, 2020-2030, Million USD

FIGURE 265.                        Africa Botulinum Toxin Market, By Gender, 2020-2030, Million USD

FIGURE 266.                        Africa Botulinum Toxin Market, By Age Group, 2020-2030, Million USD

FIGURE 267.                        Africa Botulinum Toxin Market, By End-User, 2020-2030, Million USD

FIGURE 268.                        ABBVIE INC. : NET SALES, 2018–2020 ($Million)

FIGURE 269.                        ABBVIE INC.: Primary Market Competitors

FIGURE 270.                        EISAI CO., LTD. : NET SALES, 2018–2020 ($Million)

FIGURE 271.                        EISAI CO., LTD..: Primary Market Competitors

FIGURE 272.                        EVOLUS INC. : NET SALES, 2018–2020 ($Million)

FIGURE 273.                        EVOLUS INC..: Primary Market Competitors

FIGURE 274.                        GALDERMA.: Primary Market Competitors

FIGURE 275.                        HUGEL, INC. : NET SALES, 2018–2020 ($million)

FIGURE 276.                        HUGEL, INC.: Primary Market Competitors

FIGURE 277.                        REVANCE THERAPEUTICS INC. : NET SALES, 2018–2020 ($MILLION)

FIGURE 278.                        REVANCE THERAPEUTICS INC..: Primary Market Competitors

FIGURE 279.                        IPSEN PHARMA : NET SALES, 2018–2020 ($MILLION)

FIGURE 280.                        IPSEN PHARMA.: Primary Market Competitors

FIGURE 281.                        MERZ PHARMA GMBH & CO. KGAA.: Primary Market Competitors

FIGURE 282.                        US WorldMeds LLC: Primary Market Competitors

FIGURE 283.                        MEDYTOX INC..: Primary Market Competitors

FIGURE 284.                        Sun Pharmaceutical Industries Limited: NET SALES, 2018–2020 ($Million)

FIGURE 285.                        SUN PHARMACEUTICAL INDUSTRIES LIMITED.: Primary Market Competitors

KEY PLAYERS

  • Abbvie Inc.
  • Evolus Inc.
  • Revance Therapeutics Inc.
  • Sun Pharmaceutical Industries Ltd.
  • Merz Pharma GmbH & Co. KGaA
  • Ipsen Pharma
  • Medytox Inc.
  • Galderma
  • Hugel Inc.
  • US WorldMeds LLC.
  • Eisai Co. Ltd.

Frequently Asked Questions
What will be the worth of global Botulinum Toxin market by the end of 2030?

According to the report published by Next Move Strategy Consulting, the Botulinum Toxin market business is expected to hit at $8.72 billion (USD) by 2030.

Which region is expected to hold the highest market share in the Botulinum Toxin Market?

North America is expected to hold the highest market share in the global market. The region is expected to witness remarkable growth as it houses the major key players in the market.

Which are the top companies in the Botulinum Toxin industry?

Abbvie Inc., Evolus Inc., Revance Therapeutics Inc., Sun Pharmaceutical Industries Ltd., Merz Pharma, Ipsen, Medy tox Inc., Galderma, , Hugel Inc., US WorldMeds LLC., and Eisai Co. Ltd.

What are the market segmentations and scope of the study?

The global Botulinum Toxin market share analysis is based on product, application, gender, age group, end-user, and geography.

How big is the Botulinum Toxin market?

Currently (in 2021), the market value stands at USD 4.06 billion and it is anticipated to reach USD 8.72 billion by 2030.